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     Clustered damage to the DNA is a signature mark of radiation-induced damage, which 
involves damage to the nucleobases and/or DNA backbone. Modification of the bases 
and strand breaks with the altered composition are a common occurrence at these 
clusters, imposing a difficulty in processing these lesions, requiring multiple repair 
pathways or repair factors to handle the lesions. Double-strand breaks created either 
directly or indirectly by the repair enzymes are detrimental to the cell survival, as they can 
lead to chromosomal translocations. Normal cells employ Non-homologous end-joining 
because of its faster kinetics and a limited homology requirements to suppress the 
                                                                                                 
chromosomal translocations.  However, the presence of complex DNA ends constitutes 
a significant challenge to NHEJ. One such lesion, thymine glycol (Tg), an oxidized 
thymine lesion was shown to be a lethal due to its propensity to block replicative DNA 
polymerases.  Location of Tg at the  3′ overhang proved to be a potential hindrance to 
end joining compared to an oxidized purine lesion, 8-oxo-guanine.  Positioning Tg at the 
3′ end of the blunt double-strand break also inhibited the end joining, but much less when 
moved to the third position (Tg3) from the end.  Positioning it at the fifth position (Tg5), 
however, reduced the end joining, due to increased removal of Tg from a DNA DSB end. 
Assaying for the removal of Tg by purified hNTH1 protein, Tg5 was shown to be a better 
substrate than Tg3, potentially explaining the increased Tg removal and decreased end 
joining in extracts.   Moreover, Tg at second (5′ Tg2) and third (5′-Tg3) positions at 5′ end 
of the double strand allowed for end joining even when at the second position, unlike its 
3′ counterparts, displaying no preference to processing by hNTH1. 
              Strand breaks caused either by radiation, chemotherapeutic drugs or as 
intermediates during processing other lesions, also possess unligatable ends with a 3′-
phosphate with/without 5′-hydroxyl ends. Polynucleotide kinase phosphatase (PNKP) 
enzyme is crucial in restoring the 3′ hydroxyl, and 5′ phosphate ends, thus playing a   
pivotal role in the repair of single and double strand breaks. Targeting PNKP is found to 
be beneficial in sensitizing the cells to cancer treatment, along with being a synthetic 
lethal target in cancers lacking a tumor suppressor gene. Experiments done in the current 
study to explore the activities of PNKP in its absence have revealed surprising results. 
PNKP knockout derivatives of two cell lines, HCT116, and HeLa, displayed a 3′ 
phosphatase activity on the overhang and recessed 3′-phosphate ends, in extracts, and 
                                                                                                 
also in-vivo, albeit less than the parental wild-type. Processing of the recessed ends was 
found to be lesser than the overhangs, even in the wild-type, with a substantial decrease 
in the knockouts of both cell lines.  NU7441, a DNA-PK inhibitor significantly blocked the 
activity in both wild-type and knockout extracts, while the PNKP inhibitor, ST042164 
inhibited the DNA 3′ phosphatase activity in wild-type and not the PNKP knockout. DNA 
5′ Kinase activity was also evident in PNKP knockout extracts of both HCT116 and HeLa 
cell lines. Overall, these results suggest the presence of less efficient alternatives to 
PNKP for both 3′ phosphatase and 5′ kinase activities in the cells. Also, among the core 
NHEJ proteins, XRCC4 has been shown to potentiate both activities of PNKP, while XLF 
enhanced the kinase activity.
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                                        General Introduction 
 
                       
                         Deoxyribonucleic acid (DNA) is one of the four major molecules that are 
essential for all known forms of life. It carries the genetic information encoded in order via 
the four nitrogen-containing nucleobases — cytosine (C), guanine (G), adenine (A), or 
thymine (T), a sugar - deoxyribose, and a phosphate group (nucleotides). These 
nucleotides form two biopolymer antiparallel stands bound together by base pairing rules 
(A with T, and C with G), with hydrogen bonds and form a double helix of double-stranded 
DNA. This information determines the structure, function, growth and development, and 
reproduction of the living beings. These DNA sequences are highly conserved in evolution 
and persisted as genetic information despite the constant disturbing influence. These 
insults came from the usual cellular environments or physiological events, and natural 
physical agents from external sources such as UV radiation, ionizing radiation, cosmic 
rays or human-made reactive chemicals, potentially altering the composition and integrity 
of the DNA. About 18,000 purines are lost in each cell every day, and there will be a 
conversion of about 100-500 cytosine residues into uracil by deamination. Also, DNA 
aberrations can also arise from physiological processes such as base mismatches 
introduced during DNA replication(Jackson & Bartek, 2009), or from the release of 
reactive oxygen and nitrogen species (ROS/RNS) upon oxidative respiration or through 
redox-cycling events mediated by heavy metals. Additionally, oncogenic signaling may 
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cause replication stress resulting in genome instability (Sacco, 2009). On the other hand, 
the external genotoxic agents, such as ultraviolet light from the sun, IR from cosmic 
radiation and chemical agents used in cancer therapy utilizing X-rays or radiation can 
induce a diversity of lesions in DNA including changes or losses of bases (abasic sites), 
intrastrand or interstrand crosslinks between two complementary DNA strands, SSBs and 
DSBs.  Many such damages occur in conjunction with one another resulting in "clustered 
lesions." These lesions have a propensity to block genome replication and transcription, 
and if not repaired or misrepaired, they lead to mutations or wider-scale genome 
aberrations that threaten cell or organism viability. To address the vast number of DNA 
lesions, a cell encounters each day, a myriad of elegant repair mechanisms have evolved 
to ensure faithful propagation of genetic material to daughter cells, and are essential for 
life. Hence, these repair pathways are critical and described as guardians of the human 
genome (Sishc & Davis, 2017). However, this DNA damage response might be a 
hindrance in treating cancer as DNA damage is the prime detrimental target for cancer 
chemotherapy or radiotherapy. Several inhibitors of specific proteins / factors involved in 
DNA damage response that is responsible for the survival of the cancer cells are under 
study, to sensitize the resistant cells to the regular treatments. Moreover, some of the 
tumor cells can be addicted to the protein (oncogene) for survival and/or can be defective 
in specific DNA damage response. These parameters serve as biomarkers to develop 
therapeutic strategies. Nonetheless, before considering a damage response/repair as a 
target, the mechanism of repair of a particular lesion should be elucidated appropriately 
to ensure that there is no compensatory /redundant pathway that can take over in the 
absence of the primary pathway. Radiotherapy is notorious to elicit a variety of repair 
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responses by inducing a medley of lesions in clusters and is a signature mark of radiation 
damage.  In my current study, I will be studying the repair of clustered lesions with either 
an oxidized base (Thymine glycol) or modified end (3′-Phosphate) at the double strand 
break (DSB) of DNA.   
1.1 Radiation-induced DNA damage 
 There has been extensive evidence from the radiation biology studies that DNA damage 
can result in various human pathologies such as cancer, premature aging, and chronic 
inflammatory conditions (Ciccia & Elledge, 2010). Radiotherapy is one of the primary 
modalities of cancer treatment, used either alone or in combination with surgery and 
chemotherapy and is considered as a ‘two-edged sword’ as it can induce genetic 
modifications in normal tissue along with the loss of clonogenic survival of tumor cells.   
Evidence from various animal models has shown that radiation-induced key gene losses 
in non-targeted cells can be of DNA damage response, apoptotic and cell cycle control 
genes and others, leading to secondary carcinogenesis. This damage caused by radiation 
is via linear energy transfer (LET), depositing energy in the biomolecules of cells it passes, 
causing chemical modifications. There can be either a direct deposition of energy or 
indirectly via formation of reactive chemical species in the surrounding of DNA (Ward, 
1988) (Georgakilas, 2008). Radiolysis of water in the vicinity (10 nm) of the DNA is 
primarily attributed to the production of hydroxyl radicals (OH-). The nature of lesions 
induced is similar to endogenously (ROS) produced lesions sometimes even in a fewer 
number. However, what determines the lethality of radiation is the spatial distribution of 
lesions induced along the single radiation track. While the endogenously produced 
lesions are more homogenously distributed, ionizing radiation produces two or more 
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heterogeneous lesions within one or two helical turns of DNA (Sutherland, Bennett, 
Sutherland, & Laval, 2002). Radiation track structure modeling has revealed that the 
energy deposition of low-LET radiation leads to two or more lesions within a radius of 1–
4 nM, similar to the diameter of the DNA double helix and its water layers. These signature 
lesions produced in a single track of radiation are considered as clustered damage, also 
called multiple damaged sites (MDS). These clustered lesions involve a combination of 
an oxidized purine or pyrimidine lesions, abasic sites with/ without single-strand breaks 
(non-DSB clustered lesions) and double strand breaks (DSB’S) with 3′-phosphate or 3′-
phosphoglycolate ends and/or modified sugars or bases (complex DSB’s) (Sage & 
Shikazono, 2017). These lesions can occur in the opposite strands within few helical turns 
termed as “bistranded clusters." High LET radiation (e,g., α-particles, protons, and 
carbon-ions) has an elevated propensity to form clustered DNA lesions of higher 
complexity (much denser),  even though the overall number of DSB and non-DSB 
clustered lesions does not increase, and sometimes even decreases in comparison with 
low-LET radiation (M. Hada, 2006) (Georgakilas, O’Neill, & Stewart, 2013b).  
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Fig. 1.1: Increase in LET increases the density but not the number of lesions: 
Schematic representation of increase clustering of lesions due to High Linear energy 
transfer (LET), depositing the same energy in a limited length inducing same number 
different types of DNA lesions, similar to low LET. Figure adapted with permission from 
Nikitaki et al., 2015. 
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Fig. 1.2: Schematic representation of oxidatively generated DNA damage induced 
by ionizing radiation: Oxidatively generated base damage (noted oxyPu, oxyPy, U), 
abasic site  clustered lesions at the  with no DSB, SSB within one or two helix turns of 
DNA, produced by a single radiation track, the complexity of which increases with 
increasing LET. Complex DSB are DSB associated with several oxidized bases and 
abasic sites. Figure adapted with permission from Evelyne Sage and Naoya Shikazono 
2017. 
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1.2 Biological significance and Repair of clustered lesions 
As explained above a single radiation track has the propensity to cause two main 
categories of lesions appearing in a cluster, DSB and non-DSB lesions, usually referred 
to as oxidatively-clustered DNA lesions (OCDLs).  The repair of the non-DSB cluster 
lesions is attempted by BER proteins, Apurinic/apyrimidinic endonuclease1 (APE1) or 
Poly(ADP-ribose) polymerase-1 (PARP1), as evidenced from recent studies using 
primary human fibroblasts (Das & Sutherland, 2011) or cell extracts (Kutuzov et al., 2011). 
The type of lesion, the inter-lesion distance and the orientation of nearby lesions (e.g., bi-
stranded or tandem lesions) are a rate limit to the repair process, resulting in a reduction 
or inhibition of the processing enzymes such as the glycosylases and nucleases at these 
cluster sites. This slow processing of the lesions leads to the persistence of these lesions 
until they hit a replication fork leading to the formation of chromosome breaks, mutations, 
and misrepair  (J. V Harper, Anderson, & O’Neill, 2010)(Eccles, Lomax, & O’Neill, 2010). 
There will be a formation of inadvertent DSB from these clustered lesions during the repair 
or replication (J. V Harper et al., 2010). Human AP-endonuclease-1 (hAPE1) is also 
capable of producing a DSB by cleaving the two opposite stranded AP sites. DSB can 
also result from the formation of nick in the intact strand, during processing of the 
apyrimidinic site on the opposite strand. There is a hierarchy of the repair of the lesions 
in case of three or more complex lesions to avoid the formation of DSB (Georgakilas, 
O’Neill, & Stewart, 2013a). There is a severe impairment of the excision of a base lesion 
such as 8-oxo-guanine, opposing an AP site or strand break until the AP site/strand break 
is repaired, though it occurs slowly due to the damaged opposed base (Lomax, Cunniffe, 
& O’Neill, 2004). While the radiation-induced simple prompt DSB, although carrying 3′-
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ends phosphate and phosphoglycolate can  be efficiently and accurately repaired within 
1–2 h by non-homologous end joining (NHEJ), DSB clustered DNA lesions resulting from 
either direct action of the radiation or as a result of processing of non-DSB clusters are 
repaired by non-homologous (NHEJ) or microhomology-mediated end-joining (MMEJ) 
(Behjati, et al., 2016). When the DSB is due to replication fork hitting the clustered SSB 
lesion, the repair is by homologous recombination  (Groth et al., 2012)(Arnaudeau, 
Lundin, & Helleday, 2001). Among the DNA lesions, DSB’s are considered to be most 
lethal as their misrepair can lead to genomic instability. Thus, the biological significance 
of clustered DNA  damage is not only due to the difficulty encountered by the different 
DNA repair proteins that process these closely spaced DNA lesions, but also because 
several of these OCDLs can be converted into de novo DSBs during repair.  A small 
fraction of radiation-induced DSBs, and in particular those induced by high LET radiation,  
have a slow rate of repair and to require DNA damage response via the ATM pathway. 
Thus, there is a possibility of chromosomal abnormalities arising from the repair of 
radiation-induced DNA damage via the less accurate non-homologous (NHEJ) or 
microhomology-mediated end-joining (MMEJ) (Behjati et al., 2016). leading to leading to 
structural abnormalities and subsequently to genomic instability (GI) and cancer. 
1.3 DNA Damage Response:   
 Sophisticated cellular networks sense, signal, and repair DNA lesions, constantly 
monitoring genome integrity. Depending on the type of the lesion, the repair can be by, 
but not limited to Nucleotide excision repair, Base excision repair, Homologous repair, or 
enjoining, and can function in a partial overlap. The proteins detect and bind to DNA 
lesions (sensors), activating the signaling pathways via post-translational modifications 
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of downstream proteins. Any genetic defects acquired in these response pathways induce 
a plethora of consequences affecting normal development, immunological problems, 
aging, and cancers.  In response to DNA damage, three distinct functionalities are 
activated: (1) damage detection, (2) control of cell cycle and transcriptional programs of 
damage response, and (3) mechanisms for catalyzing the repair of the lesion  (Lamarche, 
Orazio, & Weitzman, 2010). Cell cycle progression and DNA repair are tightly regulated 
via cell cycle checkpoints due to activation of orchestrated cell signaling pathways (J. W. 
Harper & Elledge, 2007). Minimal damage in the cell activates repair but not arrest, 
however with higher levels of damage there will be induction of arrest, in G1 or S, to 
prevent replication fork encounter with lesions (D. Branzei, 2009), and in G2 to prevent 
mitotic catastrophe (H. Vakifahmetoglu, M. Olsson, 2008). If the damage can’t be 
repaired, cells enter one of several programmed death pathways (necrosis or apoptosis). 
In the DNA damage spectrum, DSB’s are considered to be fatal as there is no 
complementary strand to be used as a template for repair, which can lead to 
translocations and chromosomal rearrangements due to aberrant end joining.   In any 
phase, Ku 70/80 heterodimers and MRN sensor complex are the first to detect DSB’s to 
activate and recruit apical DDR kinase ataxia telangiectasia mutated (ATM) (Uziel et al., 
2003). In S/G2 phase RPA recruits the ATM and Rad3-related (ATR) kinase via its partner 
protein, ATR-interacting partner (ATRIP) at the regions of ssDNA exposed by DSB 
processing or ssDNA at stalled replication forks (Rouse & Jackson, 2002). A third 
signaling pathway involves ATM, p38MAPK and MK2 kinases, converging on to similar 
cell cycle regulation targets such as Chk1/2. DNA PKcs, a central protein in C-NHEJ, also 
belonging to the same class Phosphatidylinositol 3-kinase-related kinase (PIKK) as ATM 
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and ATR has also been discovered to play a central role in DDR signaling, especially 
during replication stress (R.-G. Shao et al., 1999).  Although there was an initial 
compartmentalization of ATM and ATR response to frank DSBs and replication stress, 
respectively, in initial studies, there is always a functional crosstalk and overlap in the 
DDR. Mediator proteins for ATM such as BRCA1, MDC1 (mediator of DNA damage 
checkpoint) and 53BP1 (p53-binding protein 1) activate the effector kinases Chk1 and 
Chk2, spreading the signal throughout the nucleus stalling the progression of cell cycle 
(Blackford & Jackson, 2017).  
1.4 Repair of double strand breaks: 
Repair of DSB’s is by four possible mechanisms. Classic-NHEJ end ligation independent 
of sequence homology, by many factors such as Ku70/80, DNA-PKcs, and DNA ligase 
IV.  Alternatively, the DSB end can be resected leaving 3′ single-stranded DNA (ssDNA) 
overhangs can be repaired by three possible mechanisms: HR, SSA, and alt-EJ.  
However, recently a resection dependant NHEJ was discovered which is end initiated by 
Plk3/CtIP/Brca1, executed by Mre11 exonuclease, EXD2, and Exo1 execute resection, 
and completed by Artemis (Biehs et al., 2017). These repair pathways are not 
complementary and function under different circumstances. NHEJ does not require a 
template and is functional throughout the cell cycle, faster kinetics of resection 
independent repair suppressing chromosomal translocations (Difilippantonio et al., 2000) 
with resection-dependant form increasing them.(Barton et al., 2014)  HR predominates in 
the mid-S and mid-G2 cell cycle phases, when a sister template is available and is 
typically error-free (Ketki Karanam , Ran Kafri, Alexander Loewer, 2012). When classical 
NHEJ or HR is impeded because of a missing or mutated component, alternative end-
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joining pathways operate. These alternative end-joining pathways utilize the factors such 
as the MRE11–RAD50–NBS1 (MRN) complex, poly(ADP-ribose) polymerase-1 (PARP-
1), XRCC1, and DNA Ligase I or III that are involved in SSB repair (SSBR) or HR and 
there is reliance on terminal micro-homologies for the joining reactions (McVey & Lee, 
2008). SSA mediates end joining between interspersed nucleotide repeats in the genome 
and involves reannealing of Replication Protein A (RPA)-covered ssDNA by the RAD52 
protein. The intervening sequence between the repeats is deleted in the repair product, 
thus resulting in loss of genetic information (Heyer, Ehmsen, Liu, & Heyer TEL, 2010). 
1.5 Repair Pathway Selection: 
In normal cells, DNA DSB’s are repaired by two major pathways- NHEJ and HR. Many 
factors decide the choice of repair. One major factor being the cell cycle, NHEJ being 
active in all phases of cell cycle, except M-phase, and HR functioning only in S/G2 phase. 
Even in G2-phase, 70% of the two ended DSB’s are repaired by NHEJ, and the remaining 
30% by HR (Beucher et al., 2009). Irrespective of the stage of the cell cycle NHEJ factors 
Ku 70/80 and 53bp1 are the first responders to protect the free DNA ends from extensive 
resection. ATM-mediated phosphorylation of 53BP1 recruits RIF-1 protein which inhibits 
accumulation of BRCA 1 (HR factor), possibly by modulating the recognition of the 
ubiquitylated chromatin due to compaction of 53BP1 at the DSB (Escribano-Díaz et al., 
2013). BRCA1 promotes 53BP1 dephosphorylation via protein phosphatase 4 (PP4) and 
RIF1 release to favor homologous recombination (Isono et al., 2017). Further, Ku should 
be displaced from the ends for HR to be initiated by RAD51 loading (Chanut, Britton, 
Coates, Jackson, & Calsou, 2016). This process is intricately regulated by  neddylation, 
proteasome-mediated NHEJ complex degradation, phosphorylation, and MRE11-
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dependent nuclease digestion of the DNA ends. The MRN complex plays a pivotal role in 
directing a DSB down the appropriate repair pathway, via its DNA end-processing 
activities (Huertas, 2010). Mre11 with its endonuclease (HR) and exonuclease functions 
(HR, NHEJ), along with  other  exonucleases, initiates a nick or resection of  the DNA 
strand, respectively, and processes it downstream.  One of these exonucleases, C-
terminal binding protein 1 (CtIP) is phosphorylated at Ser327 position in a Plk3 (G1) or 
CDK (G2), promoting a complex formation between CtIP, Mre11 and BRCA1 (You & 
Bailis, 2010) (Barton et al., 2014). In HR, following the initial processing, other nucleases 
and helicases (i.e., DNA2, BLM, WRN) produce further resection of DSB generating 
extensive 3′ ssDNA overhangs on each side of the break.  The ssDNA thus generated is 
an excellent substrate for the HR-specific ssDNA-binding factors RPA and Rad51, 
(Huertas, 2010) and a poor one for NHEJ-specific double strand DNA termini binding 
factor Ku70/80 (Dynan & Yoo, 1998).  Several factors such as nuclear architecture, 
chromatin and transcriptional context influence repair-pathway choice. The list of the 
regulatory proteins and post-translational modifications which play a role in determining 
the destiny of the DSB’s has been increasing recently (Drané et al., 2017) (Li et al., 
2017)(Isobe, Nagao, Nozaki, Kimura, & Obuse, 2017) (Mackay, Howa, Werner, & Ullman, 
2017) . 
1.6 Homologous recombination: 
Homologous recombination is the DNA repair process which utilizes a homologous 
sequence, on a homologous chromosome or a sister chromatid for accurate DNA repair. 
This is a highly conservative process. As discussed above, the initial sensor and 
responder to localize at the DSB is the MRN complex (Uziel et al., 2003) which forms 
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nuclear foci. MRN complex incites the further steps in HR mechanism by recruiting a 
phosphatidylinositol-3-related kinase, ATM, which phosphorylates histone H2AX at 
Ser139 position forming γH2AX. MDC1, a mediator protein facilitates the binding and 
phosphorylation between ATM and H2AX. By marking one or more megabases of DNA 
surrounding the break,   γH2AX serves as a molecular beacon signaling the presence of 
damage (Davis & Chen, 2013), and forms a scaffold protein for the accumulation of other 
proteins in the repair pathway. Formation of NBS1/MRE11/Rad50, 53BP1, and BRCA1 
foci is regulated by MDC1.  The RING-finger ubiquitin ligase, RNF8, interacts with 
phosphorylated MDC1 with its FHA domain (Mailand et al., 2007), ubiquitinylates H2AX 
and facilitates the accumulation of BRCA1 at the site of damage. BRCA1-C complex, 
BRCA1-CtIP, is formed by the direct interaction of BRCA-1 and phosphorylated CtIP, and 
is recruited by MRN complex (Williams et al., 2009).  
      Cyclin-dependent kinase’s   phosphorylation of CtIP on Ser327 is essential for 
physical interactions between CtIP and BRCA1, which occurs during G2 phase of cycle. 
Upon binding to the MRN complex, CtIP catalyzes Mre11 endonuclease activity to 
introduce nicks on the DNA duplexes as far as 300 nt from DSB ends. The nick thus 
produced triggers Exo1-dependent 5′ -3′ resection, while the Mre11 exonuclease 
mediates 3′ -5′ degradation of the nicked strand toward the break releasing any other 
proteins such as Ku (NHEJ factor) bound to the DSB, thus blocking NHEJ. This extensive 
DSB end resection generates single strand DNA (ssDNA) overhangs. ssDNA binding 
complex RPA (replication protein A) coats these ssDNA overhangs initially, later 
substituted  by RAD 51, forming a nucleoprotein filament. Other recombinant proteins 
such as RAD52/RAD54 stabilize this interaction. This RAD51 nucleofilament, together 
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with various other HR factors, mediates strand invasion near a homologous sequence in 
sister chromatid or homologous chromosome. Once the strand is copied and filled in by 
DNA polymerases and ligated by Ligase I, while DNA helicase and resolvase enzymes 
mediate the cleavage and resolution of HR intermediates. 
1.7 Nonhomologous End Joining:  
NHEJ, as the name suggests, involves direct joining of the DNA ends with minimal 
processing of the ends. DSB repair in mammals appears to be primarily by NHEJ and 
has been traditionally regarded as the guardian of the genome as it prevents genomic 
instability by means of its faster kinetics of repair. Moreover, NHEJ is a flexible and 
dynamic process that can respond to variable types of DSBs (Davis, Chen, & Chen, 
2014). Physiologically, NHEJ factors in addition to protection from damage of internal 
ROS, are also crucial for V(D)J recombination for ensuring maturation of immune cells 
and for the telomere maintenance. The three main steps of NHEJ are: (I) DNA end 
recognition and assembly and stabilization of the NHEJ complex at the DNA double-
strand break; (II) Bridging of the DNA ends and promotion of end stability; (III) DNA end 
processing; and (IV) Ligation of the broken ends and dissolution of the NHEJ complex 
(Davis & Chen, 2013). Fifteen or more proteins can be involved in the processes 
assembling in a confined space around the DNA ends.  XRCC5, XRCC6, and XRCC7 
are the genes that encode some of the core NHEJ proteins that form DNA-dependent 
protein kinase (DNA-PK).  XRCC5 and XRCC6 encode the 80 and 70 kDa subunits of the 
Ku70/80 heterodimer (the DNA-binding subunit of DNA-PK), and XRCC7 encodes the 
470 kDa DNA-catalytic subunit of protein kinase DNA-PKcs (Critchlow & Jackson, 1998). 
In addition to the above factors, a heterodimer XRCC4/LigaseIV ligates the strands  
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(Critchlow & Jackson, 1998) and Cerrunnos/XLF activates the ligase activity (Critchlow & 
Jackson, 1998). Various end processing factors such as Artemis, TdT, WRN, PNK, 
hTDP1, FEN1 are required to clean the ends of the DNA of any complexities that hinder 
the direct joining and DNA polymerases λ/μ fills in the gaps created in the process.  
Proteins such as PARP-3 and APLF accelerate the NHEJ by retaining the XRCC4/Ligase-
IV complex at the site of break (Rulten et al., 2011). Since there is involvements of so 
many factors in the repair complexes, some of them required to compete for the same 
binding site, these factors have conserved protein domains or motifs such as XLF-like 
motifs (XLMs), FHA domains, Ku-binding motifs (KBMs) and BRCT domains (Rulten & 
Grundy, 2017). 
1.8 NHEJ Pathway: 
DSB associated with V(D)J recombination, irradiation or chemotherapy damage are 
primarily recognized by the MRN complex, which by further signaling via ATM, 
phosphorylates and activates H2AX to γH2AX. γH2AX recruits BRCA-1 or 53bp1,   the 
deciding factors for the pathway of repair.  In G1/M oligomers of 53bp1 flank on either 
side of the DSB bound to the histones modified by acetylases and methyl transferases. 
The chromatin conformation is thus maintained limiting access to transcription and HR 
factors (Chapman, Taylor, & Boulton, 2012), promoting NHEJ. Whenever there is a DSB, 
irrespective of the cell cycle Ku is the initial protein (Reid et al., 2015) to translocate to the 
site and binds dsDNA ends with extremely high affinity (Lieber, 2010) and encircles the 
DNA with its preformed channel (Walker, Corpina, & Goldberg, 2001). This binding occurs 
in an ATP dependent manner (Dynan & Yoo, 1998) and prevents the DNA ends from 
further damage. Ku functions as a signal molecule for the recruitment of further NHEJ 
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proteins. Recently, it has been shown that Ku can process the ends of the DNA by virtue 
of its 5′-dRP/AP lyase activity, processing the abasic sites by nicking DNA 3′ of the abasic 
site via a Schiff-base covalent intermediate (Fell & Schild-Poulter, 2015). After its binding 
to the ends, there will be an inward translocation of Ku and recruitment of DNA-PKcs to 
form a Ku-DNA-PKcs synaptic complex (DNA-PK) which tethers the DNA ends together 
and offers protection from premature nucleolytic degradation (Smith & Jackson, 1999). 
Further, synapsis of the juxtaposed DNA ends stimulates autophosphorylation of DNA-
PKcs by DNA-PK kinase activity, inducing a conformational change in the DNA-PK 
complex, mobilising it internally away from the  DNA strand breaks,  providing access to 
other  factors (Calsou et al., 1999). In addition to DNA-PKcs, DNA bound Ku also recruits 
XRCC4/Ligase IV complex and XLF independently (Yano & Chen, 2008). The recruitment 
of the proteins does not require any protein-protein interactions but the assembly of the 
proteins does. XRCC4 requires DNA-PKcs, and XLF requires XRCC4 to be retained at 
the repair loci. Once recruited, XLF and XRCC4 form a nucleo-filament around the DNA 
ends by interacting in a head-head manner. The architectural channel thus formed with 
the synergy of Ku-XLF-XRCC4 interaction, stabilizes DSBs and provides accessibility and 
activation of Ligase IV (Hammel et al., 2011). Ligase IV is ATP-dependent and uses ATP 
to adenylate itself to transfer AMP to the 5′- phosphate of one end of DSB. AMP gets 
removed by the nucleophilic attack by the 3′ hydroxyl group of the second DSB end, 
yielding a ligation product. XLF stimulates LIG4-mediated ligation via promoting re-
adenylation of Ligase IV (Davis et al., 2014). One distinctive feature of Ligase IV is its 
ability to ligate incompatible DNA ends across gaps. Ligation of mismatched and non-
cohesive ends is stimulated by XLF. As expected of it, NHEJ is an error-prone pathway 
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(Lieber, Ma, Pannicke, & Schwarz, 2004), as there will be often removal of the nucleotides 
and fill in without the guidance of a template. Loss of nucleotides during the process 
makes the DSB repair inaccurate.  Except for the recruitment of the Ku heterodimer, the 
order of recruitment of other factors is flexible depending on the complexity of the DNA 
damage (Reynolds et al., 2012).  The recruitment of the NHEJ machinery to the site of 
the DSB occurs via a dynamic assembly (Yano, Morotomi-Yano, Adachi, & Akiyama, 
2009), rather than a step-wise sequential manner. Ku heterodimer, XRCC4, Ligase IV 
and XLF are sufficient for the repair of simple DSB, whereas complex breaks require 
DNA-PKcs and ATM activation of a multitude of repair factors to enhance processing of 
the damage. As the IR produces complex DSB's with 3′-phosphate or 3′-phosphoglycolate 
groups, 3′ and 5′ overhangs with damaged bases and/or ribose units in the vicinity of the 
break ends (Nikjoo, O’Neill, Wilson, & Goodhead, 2001), the DNA ends must be 
processed before ligation. Enzymes such as Polynucleotide Kinase 3′-Phosphatase 
(PNKP), Artemis, FEN-1, WRN, hTDP1, Polymerases belonging to Pol X family (μ and 
λ), aid in the processing of the complex DNA ends. DNA Polymerases serve two important 
roles, fill-in synthesis of gaps and nucleotide addition to broken DNA ends. Pol μ primarily 
adds nucleotides in a template-independent manner, whereas Pol λ primarily has 
template-dependent polymerase activity. While Pol  PNKP removes the 3′- phosphate 
from the DNA ends, Artemis removes the hairpin bend at the the V(D)J associated DSB, 
metnase trims the damaged ends (Mohapatra et al., 2013), nucleases remove several 
nucleotides from single-stranded overhangs at the DSB ends termini,  aprataxin   removes 
adenylate groups from the 5′ end (Ahel et al., 2006b) , the phosphodiesterases TDP1 and 
TDP2 process DNA topoisomerase adducts (Lee et al., 2012), DNA poly merases 
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belonging Pol X family fill in the gap, FEN-1 has an exonuclease function, WRN (Werner 
syndrome helicase) and BLM (Bloom syndrome helicase) are the unwinding enzymes 
(Lee et al., 2012). This extensive processing of the DNA end can result in deletions and 
insertions leading to inaccuracy in repair. Even though cNHEJ is inherently error-prone, 
there are greater risks associated with cNHEJ defects as the back-up alt-NHEJ pathway 
creates larger deletions, mediating translocations (Corneo et al., 2007) (Deriano & Roth, 
2013). 
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Fig. 1.3: Schematic overview of NHEJ: i) Illustration of a double-strand break (DSB). ii) 
Recognition of the DSB produced by an by the heterodimer protein Ku. iii) Recruitment of 
the DNA PKcs by Ku and formation of DNA-PK complex by the activation of its kinase 
activity. iv) Autophosphorylation of DNA-PKcs shifts the complex inwards exposing the 
DNA ends for the processing enzymes. XRCC4-Ligase IV complex in combination with 
XLF forms a filament around the broken ends, and vi) once the ends are processed by 
specific accessory factors, DNA Ligase IV ligates the ends, vii) followed by disassembly 
of the complex after restoring the DNA integrity. Figure adapted with permission from 
Grundy et al., 2014.  
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1.9 NHEJ – Guardian or Disruptor of the genome? 
There is contrasting evidence giving rise to the debate if NHEJ is indeed a protector from 
genomic instability. There are numerous studies undermining the role of core NHEJ 
factors in promoting healthy neurological and immunological development of the 
organism, protection from premature aging and the development of carcinogenesis as 
evidenced by increased tumor rates in mouse-models lacking core NHEJ factors(Buck et 
al., 2006)(Yan et al., 2006) (Espejel et al., 2004)(Gao et al., 2000). Surprisingly, studies 
in human cells, in which site-specific DSBs are introduced using nucleases at 
endogenous loci, translocation reporter assays, or  DSBs induced by radiation, found that 
NHEJ is responsible for the generation of translocations (Rothkamm, Kühne, Jeggo, & 
Löbrich, 2001) (Weinstock, Richardson, Elliott, & Jasin, 2006)(Lieber, Gu, Lu, Shimazaki, 
& Tsai, 2010). Furthermore, NHEJ is found to be the culprit behind the translocations in 
human lymphoid cells and renal cell carcinoma (RCC), with the characteristic small 
deletions near the DSB sites, and DNA polymerase μ or Pol λ mediated template-
independent nucleotide insertion (Lieber et al., 2010) (Ali et al., 2013). Chromosomal 
translocations can be a consequence of inaccurate end joining of two independent DSBs 
on different chromosomes by NHEJ. The probability of this will increase during an 
attempted repair of highly complex lesions, or repair of one ended DSBs due to a failure 
of HR or pathways such as Fanconi anemia pathway which directs this one ended DSBS 
towards HR (Romick-Rosendale et al., 2016).  Interestingly, DNA-PKcs-dependent NHEJ 
is found to play a role in Chromothripsis, a result of randomly rejoined multiple DSBs of a 
chromosome (Ali et al., 2013). Probing into this controversial data researchers have also 
found out the role of differential regulation and single nucleotide polymorphisms (SNPs) 
21 
 
in the core NHEJ genes that correlate with cancer incidence, tumor aggressiveness, and 
responsiveness to conventional radiation and chemotherapy. Some tumors have shown 
either a decrease of Ku70 levels or DNA-PKcs levels (colon, endometrial, breast and 
lung) (Beggs et al., 2012) (Lomnytska et al., 2012) (Lomnytska et al., 2012) (Auckley et 
al., 2001), or increase of Ku70 levels or DNA-PKcs levels  (myeloid, gastric and colorectal) 
(Gaymes, Mufti, & Rassool, 2002) (H. Hu, Zhang, Zou, Yang, & Liang, 2010) (Auckley et 
al., 2001), which drive carcinogenesis. Similarly, high Ligase IV expression (prostate 
cancer) (GRUPP et al., 2015) or reduced Ligase IV expression, (colorectal cancer)  
(Kuhmann et al., 2014) causes tumorigenesis. Also, XLF overexpression in HPV(+) 
HNSCCs and down-regulation in HNSCC cells expressing high levels of mutant p53, 
promote chromosomal instability and cancer (Feng et al., 2016). Further, genetic single 
nucleotide polymorphisms (SNPs) in the core NHEJ factors are found to be associated 
with either carcinogenesis (Feng et al., 2016) (Schildkraut et al., 2010) (Wang et al., 2008) 
(Hsu et al., 2009), or reduced risk of cancer (Adel Fahmideh et al., 2016) (Andrew et al., 
2015) (Roddam et al., 2002). Differential expression of the NHEJ core factors also 
influences the therapeutic responsiveness. While the reduced levels of expression 
increase the sensitivity to therapy (Hu et al., 2013) (Tarish et al., 2015) (Jin et al., 2016),  
increased levels promote resistance (Jin et al., 2016) (C.-J. Shao, Fu, Shi, Mu, & Chen, 
2008) (Shintani et al., 2003). Though traditionally NHEJ is error-prone in the repair of non-
compatible DSBs, it is likely to be much more precise than previously believed due to the 
flexibility of the NHEJ factors. Nonetheless, cells that are deficient in HR and FA pathways 
direct the one-ended DSBs towards NHEJ resulting in chromosomal aberrations, 
promoting carcinogenesis. This is because the cell would rather tolerate a chromosomal 
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aberration than having an unrepaired DSB which can result in the cell demise (Douglas, 
Moorhead, Ye, & Lees-Miller, 2001). Therefore, FA and HR-deficient cells, as a 
compensation often overexpress NHEJ factors and become addicted to NHEJ to deal 
with a large number of DSBs generated during rapid cell proliferation.  Considering the 
above scenarios, one can conclude that normal cells use NHEJ to stabilize the genome, 
but precancerous and cancer cells utilize NHEJ to drive genomic instability and 
carcinogenesis. 
All the above observations have led to manipulating, either genetically or 
pharmacologically the NHEJ factors to sensitize and improve the responsiveness of 
individual cancers to therapy (Jun et al., 2016) (Riabinska et al., 2013) (Winkler, Hofmann, 
& Chen, 2014). However, only pharmacological intervention is clinically applicable 
currently. Molecular compounds that inhibit either protein-protein, protein-DNA 
interactions (Douglas et al., 2001), or activity of the factors with a kinase and/or 
phosphatase activity are being explored (Leahy et al., 2004) (Douglas et al., 2001). One 
potential problem to translate the in-vitro inhibitor studies to in-vivo is the reduced drug 
uptake. Strategically, these inhibitors can be utilized for inducing synthetic lethality. This 
approach is recently applied by using DNA-PKcs inhibitors in the treatment of various 
cancers including ATM-defective tumors, HR-deficient tumors, and MSH3 deficient 
tumors (Lan et al., 2016) (Yanai et al., 2017) (Douglas et al., 2001).  DNA-PKcs inhibitor, 
CC-115 (Tsuji et al., 2017) is undergoing Phase I clinical trial to be used as an adjunct to 
radiation therapy or chemo-radiation therapy. 
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1.10 Base Excision Repair 
DNA base damage frequently occurs in the cells, at least 10,000 times every day, 
spontaneously or by oxidative stress induced by ROS generated by endogenous and 
exogenous sources. Oxidation, alkylation, or deamination are the common ways 
modifying these bases. Some examples of the modified bases are 7,8-dihydro-8-
oxoguanine (8-oxoG), 5-methylcytosine  (5-meC), (6-meG), N7-methylguanine (7-meG), 
or N3-methyladenine (3-meA). While some of these lesions are premutagenic, some of 
them are cytotoxic due to their propensity to block replicative polymerases (Lindahl & 
Wood, 1999). Various repair pathways take care of these lesions depending on the nature 
and complexity of the lesions. One such highly evolved pathway is the Base Excision 
repair (BER) pathway mends single oxidized base lesions. There are three functional 
processes involved in the repair, 1. Lesion Recognition/Strand Scission, 2. Gap Tailoring, 
and 3. DNA Synthesis/Ligation. Each step involves specific protein(s) in a coordinated 
fashion such as DNA glycosylases (mono or bi-functional), AP-endonuclease, DNA 
polymerases, and ligases. There is about 11 DNA glycosylase discovered and classified 
into four structurally distinct superfamilies, the uracil DNA glycosylases (UDGs), the helix-
hairpin-helix (HhH) glycosylases, the 3-methyl-purine glycosylase (MPG), and the 
endonuclease VIII-like (NEIL) glycosylases. These DNA glycosylases scan the DNA via 
4Fe4S, employing a damage pre-selection strategy to minimize the effort (Banerjee, 
Yang, Karplus, & Verdine, 2005). Mono-functional glycosylates such as UDG, excise the  
N-glycosidic bond by hydrolysis (Mol et al., 1995) releasing damaged base creating an 
apurinic/apyrimidinic sites (AP-site). AP endonuclease (APE1), cleaves the AP-sites on 
the 5′ side of the lesion leaving a 3′-hydroxyl and 5′ deoxyribose phosphate termini (5′-
24 
 
Rp). The 5′-dRp termini are taken care of Pol β in case of short patch BER. Bi-functional 
glycosylases, on the other hand, have an AP-lyase activity which cleaves the AP-lesion 
on the 3′side producing a 3′- unsaturated aldehydic end (β-elimination) with a 5′phosphate 
end (NTH1) or a 3′-phosphate and a 5′phosphate end (β and δ elimination) (NEIL). The 
3′- the unsaturated aldehydic end is further cleaved by APE1, and the polynucleotide 
kinase phosphatase (PNKP) converts the 3′-phosphate end to 3′-hydroxyl end. After 
processing the removal of the damaged base, the glycosylases are tightly bound at the 
AP-site and requisite APE1 for their release and turnover (Almeida & Sobol, 2007). The 
nick and the gap in the DNA strand are further recognized by the XRCC1, which along 
with Ligase III and Pol β fills in the gap and ligates the strand as a part of short patch 
BER. Under the conditions when a 5′ lesion is refractory to pol β lyase activity, long patch 
base excision pathway kicks in (Gary, Kim, Cornelius, Park, & Matsumoto, 1999).  During 
long patch repair the polymerases δ, ɛ or β function in concert with other proteins such 
as proliferating cell nuclear antigen (PCNA), structure-specific flap endonuclease (Fen1), 
poly(ADP-ribose)polymerase 1 (PARP1) and LigI, to synthesize DNA to fill in the gap up 
to a length of 13 bases. This newly synthesized DNA displaces the 5′ end blocking strand 
creating a flap which will be cleaved by FEN1.  
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Fig. 1.4: Oxidative DNA base damage repair through BER-pathway:  Initiation of BER 
is by removal of the modified base by either a monofunctional (M) or bifunctional (B) DNA 
glycosylase (DG), which leaves an AP site. If monofunctional enzyme cleaves the 
glycosidic bond APE1 incises the DNA backbone 5′ to the AP site. The single strand 
breaks (SSBs) left by the both DG and MG contain either a 3′ or 5′ obstructive termini. 
These end breaks are recognized by PARP1and processed by pol-β, APE1 or PNKP 
depending on the specific nature of the terminus. When 3′-OH and 5′-P termini result from 
end processing, the BER and SSBR diverge into two sub-pathways, short-patch (SN) and 
long-patch (LP) BER/SSBR. In SN-BER/SSBR, the single nucleotide gap is filled in by 
pol β aided by the XRCC1 scaffold in the presence of PNKP and ligated by Ligase III. In 
LP-BER/SSBR, Pol δ/ε with the aid of PCNA, 2 to 13 nucleotide gap is filled in, and the 
resulting 5′ flap is removed by FEN-1. As with the SN-BER final ligation step is 
accomplished by Ligase I. Figure adapted with permission from A.K. Mantha et al. 2014. 
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RESOLUTION OF PROXIMAL THYMINE GLYCOL AT DSB TERMINI BY BASE 
EXCISION REPAIR AND ITS INTERFERENCE IN NONHOMOLOGOUS END JOINING 
OF FREE RADICAL-MEDIATED DNA DOUBLE-STRAND BREAKS 
                                                    
                                                        II. Introduction                                                     
 
2.1 Thymine glycol lesions: 
As discussed before, the formation of oxidative lesions is not uncommon even under 
normal physiological conditions. During irradiation, the energy deposition is proportional 
to mass, and hence the purines (adenine and guanine) and pyrimidines (cytosine and 
thymine) are about equally likely to sustain damage through the direct mechanism (JF, 
1988). Thymine glycol is the most easily damaged base formed due to oxidation of 
thymine or deamination and oxidation 5-methylcytosine by ionizing radiation or cancer 
therapy (Adelman, Saul, & Ames, 1988). Radiation generates oxidants that can react with 
thymine leading to the formation of thymine glycol, thymine peroxide, thymine hydro 
peroxide, and other oxidized forms of the base. Further reaction to these products yields 
urea.  Approximately 10%-20% of the radiation or radiotherapy-induced damage results 
in thymine base oxidation and DNA fragmentation(Kung & Bolton, 1997). Thymine glycol 
has four diastereomers of, i.e. (5R, 6S), (5R, 6R), (5S, 6R) and (5S, 6S), but in solution 
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exists as either the 5R cis-trans pair [(5R, 6S) and (5R, 6R)] or the 5S cis-trans pair [(5S, 
6R) and (5S, 6S)], due to epimerization at the C6 position (Lustig, Cadet, Boorstein, & 
Teebor, 1992). Oxidation of free thymidine or thymidine in the oligonucleotides 
preferentially yields (5R, 6S)-thymine glycol (Kao, Goljer, Phan, & Bolton, 1993a) 
(Vaishnav, Holwitt, Swenberg, Lee, & Kan, 1991). According to calculations, cis-(5R,6S) 
diastereomer is the most stable one amongst all the isomers of thymine glycol. Depending 
on the original base that is oxidized, Tg is found to pair with either A (Thymine) or G 
9methyl-cytosine). Thymine glycol has the propensity to cause both structural and 
functional perturbations of the DNA.  The free radical addition to the C (5)C (6) double 
bond of thymine produces a nonplanar ring-saturated lesion making it extra helical as 
shown by NMR studies and by its accessibility in the solution (Kao, Goljer, Phan, & Bolton, 
1993b) (Kao et al., 1993b).   Two possible consequences of Tg lesions are either it blocks 
the DNA polymerases or gets bypassed by translesional synthesis and become 
mutagenic.  
               Unlike 8 oxo-guanine, Tg is a weak mutagen (Ashis K Basu et al.,1989), but a 
potent blocker of both DNA repair and replicative polymerases, proving lethal to the cells 
in the absence of translesional synthesis or recombination (Wallace, 2002). Studies using 
a template containing thymine glycol for primer extension with several DNA polymerases 
have shown that the extension occurs up to the site of Tg with adenine insertion and not 
beyond, especially if the 5′-neighbor is a purine as the protruding C5 methyl group of Tg 
pushes the purine extra-helical. This displaced base will be stabilized by the hydrogen 
bonds between NH2 and N3 of G on the minor groove’s side and C4 and C5 hydroxyls of 
Tg on the major groove’s side. This limits the next incoming dNTP incorporation into the 
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primer strand, providing a rationale for the strong bock to replication (Ide, Kow, & Wallace, 
1985) (R C Hayes & LeClerc, 1986). This effect is less evident if the 5′-neighbor is a 
pyrimidine. Meanwhile, there are several contexts in which thymine glycol is bypassed by 
certain DNA polymerases in vitro (R C Hayes & LeClerc, 1986) and in vivo (A K Basu, 
Loechler, Leadon, & Essigmann, 1989).   
               Repair of a simple thymine glycol lesion is major via single nucleotide patch 
base excision repair pathway (A K Basu et al., 1989) and in part by Nucleotide excision 
pathway (NER) and by recombination. Enzymes Endonucleases III and VIII in E.coli and 
their human homologs Nth1 and NEIL (1,2,3) respectively, stereoselectively repair 
thymine glycol lesions (Katafuchi et al., 2004). 5R Tg is preferentially removed from 
chromosomal DNA in irradiated human cells, whereas 5S Tg is preferentially excised in 
irradiated E. coli cells (Shibata, 2017). The repair is sequence and counter-base 
dependent, Tg.G being repaired more efficiently than Tg.A by NEIL 1 (Marenstein et al., 
2003). The counter base and the accompanying sequences have the propensity to either 
block the replication or promote misinsertion during translesional synthesis (Dolinnaya, 
Kubareva, Romanova, Trikin, & Oretskaya, 2013a). 
     In tandem lesions of 5′- abasic site and Tg, there is a severe replicative block and if at 
all bypassed the lesion becomes highly mutagenic, especially if accompanied by 3′-G due 
to a misalignment-realignment mechanism (Huang, Imoto, & Greenberg, 2009). If the 
tandem lesions have 5′-(8-oxoG)Tg and 5′-Tg (8-oxoG), there is enhanced mutagenicity 
of these lesions compared to 8-oxoG alone. In contrast, there is enhanced repair of 8-oxo 
G by hOGG1 in case of 3′-Tg but unaffected by 5′-Tg. In case of bistranded lesions, if Tg 
is opposite the abasic site, BER or replication induce a double strand break, while the 8-
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oxo G protects at the expense of increasing mutations. At the double strand break, if 
present in an overhang, 8-oxoG is more tolerant than thymine glycol (R.-Z. Zhou et al., 
2008a). In the current study, we are evaluating the role of Tg in end-joining when present 
at a blunt double-strand break.  
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Fig. 2.1: Formation of thymine glycol:  Reactive oxygen species (ROS), such as 
peroxide and hydroxyl radicals, are generated as byproducts during normal oxidative 
metabolism, and ionizing radiation modifies DNA bases. A typical product of thymine 
oxidation is thymine glycol. Figure adapted from  Aller et al. 2007. 
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2.2 Human EndoIII like protein (hNTH1):  
hNTH1 enzyme is a bifunctional DNA N-glycosylase/apurinic/apyrimidinic (AP) lyase and 
a human homolog of E. coli endonuclease III. hNTH1 removes ring-saturated pyrimidines, 
be they hydrated, reduced, or oxidized, from the DNA backbone as the initial step of base 
excision repair (BER).  It is a product of the OCTS3 gene, 312 amino acids in length with 
a calculated molecular mass of 34,300 Da. Like its other homologs, the hNTH1 sequence 
has highly conserved four cysteine residues donning a binding motif for the [4Fe-4S] 
cluster, and a helix–hairpin–helix motif that has been shown in the case of E. coli 
endonuclease III to contribute to DNA binding of the enzyme (Thayer, Ahern, Xing, 
Cunningham, & Tainer, 1995). The Lys-220 in the helix–hairpin–helix motif interacts with 
the flipped out damaged base, thymine glycol in the current scenario but is not a specific 
substrate. The ε-amino group of this lysine catalyzes the formation of N-acylimine (Schiff’s 
base) enzyme-substrate intermediate, which is essential for the enzymatic catalysis of 
the β-elimination, a characteristic of an APlyase. The hydrolysis of the Schiff base 
intermediate by acid-base catalysis at the active site produces an AP site with the release 
the damaged base and abstraction of the deoxyribose pro-S-2′-hydrogendeoxyribose 
sugar at the site results in a strand break with 3′ α,β unsaturated aldehyde and a 
5′phosphate (Marenstein et al., 2003). It was noted that AP-lyase function is 7 times 
slower than the DNA glycosylase activity (Ikeda et al., 1998). The 3′-dRp generated at 
the AP-site is later cleaved by APE1 to produce a 3′-hydroxyl end which can further be 
filled in by Polβ, and ligated by Ligase IIIα. 
 
 
32 
 
 
 
 
                              
 
 
 
 
 
 
 
Fig. 2.2: Schematic representation of removal of Thymine glycol by NTH1 protein: 
The flipped out Tg lesion on the DNA strand is recognized and removed by NTH1, 
followed by β-elimination of the AP-site producing a 3′-deoxyribose phosphate (3′-dRp) 
as a unsaturated aldehyde. 3′dRp is further cleaved either by APE1  to leave a 3′ hydroxyl 
end. The resulting gap is filled in by Polβ and LigaseIIIα ligates the strand. 
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                                                 Hypothesis 
  
 
 
Thymine glycol (Tg) is better removed from the substrate when placed away from the 
double strand DNA break by Base Excision Repair with possible interference with 
Nonhomologous end joining. 
 
Background: 
 
Previous experiments done with Tg positioned at various positions, first (Tg1), second 
(Tg2), third (Tg3) and fifth position (Tg5) at the blunt DSB have shown the end joining in 
the order of Tg3>Tg5>Tg2>Tg1, in Bus whole cell extracts. This observation was in 
contrast to our expectation that Tg5 will be joined efficiently due to Tg placement away 
from the break. Also, we saw an extra product, 3 or 5 bases lesser, being formed during 
repair of Tg3 and Tg5, respectively, corresponding to a product that would result from the 
removal of Tg from the third or fifth position of the corresponding substrate.   This product 
was more prominent for Tg5 than for Tg3. Since Tg is a substrate for hNTH1 of BER, we 
wanted to verify if Tg5 is a better substrate for hNTH1, which might have resulted in the 
reduction of the end a joining due to the interference of BER with NHEJ. Similarly, we 
wanted to test the preference of hNTH1/BER for 5′-Tg’s. 
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2.3: Specific aims 
 
1. To compare the processing of the substrates with Tg placed at third position from 
the 3′-end of the DSB (Tg3) to that of Tg placed at fifth position (Tg5) by the 
recombinant hNTH1 protein 
 
2. To compare the processing of Tg placed at second position from the  5′-end (5′-
Tg 2) o that of Tg at third position at the 5′-end (5′-Tg 3) in Bus cell extracts with 
XLF and by  the recombinant hNTH1 
 
3. To verify the processing of 3′ and 5′-Tg substrates in HCT116 cell extracts 
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                               III. Materials And Methods 
 
 
3.1 Substrate 
The oligonucleotides, 5′-ATGCGGATCGCGTTGTCTg-3′ (Tg1), 5′-
ATGCGGATCGCGTTGCTgC-3′  (Tg2), 5′-ATGCGGATCGCGTTG-Tg-CT-3′ (Tg3) and 
5′-ATGCGGATCGCGT-Tg-GT CT-3′ (Tg5) were ordered from Midland Certified 
Reagents (Midland, TX).  They were re-suspended in TE (10 mM Tris–HCl, pH 8, and 0.1 
mM EDTA). 1mCi of [γ-32P] ATP was used to label 50 pmoles of the oligonucleotide, using 
Polynucleotide kinase (PNK) and incubated for 1 hr at 37 °C. Each oligomer was then 
annealed to an equal quantity of a complementary 5′- phosphate containing, 3′-
GTATACGCCTAGCGCAACGAGp-5′ or 3′-GTATACGCCTAGCGCAACAGAp-5′, via 
heating to 80 °C followed by slow cooling to 10 °C. The duplexes generated by this 
annealing process included, on one end a 3-base 3′overhang that was complementary to 
the 3′ overhang created by BstAPI digestion of pUC19.   
3.2 Ligation of oligomeric duplexes to the KasI/BstAPI cleaved pUC19: 
17 μg of the plasmid pUC19 DNA is digested with 50 units of KasI (NEB) in 0.3 ml of NEB 
CutSmart buffer for 3 hr at 37 °C and then digested with 50 units of BstAPI in the same 
buffer for 3 hr at 60 °C. The 2.6-kb KasI-BstAPI fragment was purified on a 0.8% agarose 
gel, electro eluted and concentrated with an ultracel 100k centrifugal filter.  
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      10 pmole of the annealed oligomers were combined with (~1.7 pmole) of KasI/BstAPI 
fragment and treated with 12,000 units (4 μl) T7 DNA ligase in to ligate them at the BstAPI 
end in 130 μl of ligation buffer for 2 hr at 25 °C. Proteolysis and ethanol precipitated 
extraction of the ligation products is done. These products are then digested with SmaI 
(500 units) for 2 hours at 25 °C in 50 μl CutSmart Buffer. This removes 177 bp from the 
KasI-end and leaves a blunt end. The resulting 2.6-kb substrate has one Tg-modified end. 
This substrate is electro eluted and concentrated as above. T7 ligase was used for ligase 
instead of T4 ligase due to its preferential ligation of only cohesive and not the blunt ends 
(Doherty at al. 1996; Subramanya et al.1996). Some self-ligation was detected in case of 
the unmodified control oligomers, and therefore for these oligomers, the T7 Ligase was 
reduced to only 2400 units. In the case of Tg5 plasmid there some ligation seen between 
head-head blunt ends, and cutting the plasmid with Sma I enzyme would have eliminated 
any head-tail ligation. The ligation products were purified by agarose gel electrophoresis 
and electroelution (Bennett et al. 1996).   
3.3 Electroelution of the modified substrate: 
The nucleotide is electroeluted using an 11-inch segment of pretreated dialysis tubing 
(6,000-8,000 molecular weight) filled with the buffer composed of 20 mM Tris, pH8 and 1 
mM EDTA (the elution buffer). The gel slice containing the desired DNA band was placed 
in the dialysis tubing, and the other end of it was knotted after removal of air bubbles. The 
dialysis tube was placed in a gel box filled with the same buffer, and the DNA was eluted 
overnight at 50 V.  Then the dialysis bag was cut, and the buffer containing DNA substrate 
was collected into 15 ml centrifuge tubes. 0.45 μm filters were used to remove any debris, 
and the DNA was concentrated by micro- concentration to about 500 μl using centricon-
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100 (Amicon). The concentrate was collected into 1.5 ml Eppendorf tubes and 
precipitated with 1/9 volumes of NaOAc and 2.5 volumes of 100% EtOH, washed with 
70% EtOH and dissolved in 50 μl TE. 
3.4 Bus cell and HCT116 cell extract preparation: 
      Bus cells were grown into confluence on thirty 15 cm dishes each with 20 ml alpha-
MEM medium with 10% FBS. HCT116 cells were grown to a confluency of 70% - 90% 
and then serum starved with 0.5% FBS for 4 days. On the day of the experiment, the 
dishes were washed with 20 ml PBS at room temperature. 3 ml of 0.25% trypsin-EDTA 
was added to each dish, making sure it covers all the cells. They were incubated for 5 
min until the cells are detached and then 3 ml medium and serum was added. These 
samples were collected and pelleted in 50 ml tubes at 1500 rpm for 5 min in ultracentrifuge 
using SW55 rotor at room temperature. The cells were resuspended in 50 ml medium 
and serum and pelleted again. The pellet was again resuspended in 25 ml medium and 
serum and pelleted again. The pellet was resuspended in 30 ml ice-cold PBS and pelleted 
at 4 °C and packed cell volume (PCV) is recorded. The last process was repeated. The 
pelleted cells were resuspended in 5 X PCV cold hypotonic buffer containing 10 mM Tris-
HCl pH 8, 1 mM EDTA, 5 mM DTT and proteinase inhibitors pepstatin 1 μg/ml, 
chymostatin 1 μg/ml, aprotinin 2 μg/ml, leupeptin 1 μg/ml, PMSF 1 mM.  The cells were 
quickly pelleted. This pellet was again resuspended in 2 X PCV hypotonic buffer and 
inhibitors and let set on ice 20 min. 1.5 ml of this solution was put in a small dounce 
homogenizer each time and stroked 20 times. After it was let set for 20 min, it was 
transferred to cold 5 ml centrifuge and ¼ volume of the hypertonic solution ( 83.5 mM Tris 
Ph 7.5, 1.65 M KCl, 3.3 mM EDTA, 1 mM DTT) and inverted several times to mix well. 
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This was centrifuged at 43K for 3 hr in SW55 at 2 °C. From the top the middle layer which 
has cytosol was collected using a 22G needle, avoiding cloudy layer on the top. The 
cytoplasm thus collected was dialyzed for 3 hr in storage buffer (20 mM Tris pH 8, 0.1 M 
KOAC, 1 mM DTT, 0.5 mM EDTA, 20% glycerol) with inhibitors at 4 °C. The resulting 
solution was freezed in small aliquots (10 μl - 80 μl) at -80 °C. 
3.5 End joining assays using cell extracts: 
Bustel whole cell extracts which are deficient in XLF or HCT116 whole cell extracts were 
used for the reactions in a buffer containing 50 mM triethanolammonium acetate (pH 8), 
1 mM ATP, 1 mM DTT, 50 μg/ml BSA, 1.3 mM Mg(OAc)2 and dNTPs at 100 μM each. 
The total reaction volume was 16 μl, with 10 μl of extract, resulting in a final protein 
concentration of 8 mg/ml. 200 nM of human recombinant protein XLF was substituted for 
some reactions. 100 ng of the substrate was added and the reaction mixed by pipetting 
and incubated at 37 °C for 6 hr. Samples were deproteinized by adding an End Joining 
Lysis buffer containing 1 mg/ml of Proteinase K for 3 hr at 56 °C. The DNA was then 
extracted after proteolysis and precipitation with glycoblue and ethanol after one hour. 
After the precipitation, all samples were dissolved in 43 μl of TE and digested with 20 
units of NdeI and PstI and 5 μl of 10X CutSmart buffer (New England Biolabs) at 37 °C 
for 3 hr. Gel electrophoresis of the samples was done in 20% polyacrylamide sequencing 
gels. Then the gels were exposed to phosphor imaging screen for 1 to 2 days at -20 °C.  
Data were analyzed using a Typhoon 9100 imager (GE Healthcare Bio-Sciences, 
Pittsburgh) and Image Quant 3.1 or 5.1 software (GE Healthcare Bio-Sciences, 
Pittsburgh). The percentage of end joining was determined by measuring the percentage 
radioactivity of the joined fragments as a function of total radioactivity in the same lane. 
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3.6 Polyacrylamide gel electrophoresis: 
For electrophoretic separation of the DNA strands, Polyacrylamide gels (20x30x0.08 cm)   
containing 40% acrylamide: bisacrylamide in a ratio of 20:1, 8 ml of 10XTBE and urea in 
a final concentration of 8.3 M were used in total volume of 80 ml. The mixture was cooled 
to room temperature, and 0.06 g ammonium persulfate and 45 μl of TEMED (N’, N,’ N’, 
N’-tetramethylethylene diamine) were added. The gel was allowed to polymerize for 1 
hour. 15 μl of samples are then loaded into the wells of the gel and electrophoresed at a 
constant power of 42 W until the marker reached the bottom of the gel.          
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Fig. 3.1: Preparation of the substrate: The oligonucleotide with Tg was radiolabeled 
with P32 at 5′ end is annealed with a complementary strand. This was ligated to the BstAPI 
cut end of the pUC19 using T7 DNA Ligase. The substrate thus prepared had a head with 
BstAPI and NdeI restriction sites and a tail with SmaI and PstI restriction sites. This 
substrate was used in both cell extract ligation assay and assay with recombinant 
proteins. 
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                                                Preliminary Data  
 
 
 
 
3.2 Comparison of the repair between Tg3 and Tg5: A) Autoradiograph showing the 
repair (joining and BER) fragments of Tg0, Tg3, and Tg5 in Bus cell extracts 
supplemented with XLF. B) The graph is representing the percentage of both joining and 
BER fragment for Tg3 (16-bp) and Tg5 (14-bp). (n = 3) 
 
 
 
A. B. 
 1  2   3  4  5  6   
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IV. Results 
 
 
                        Double-strand breaks induced by DNA damaging agents have the 
propensity to turn lethal for cell survival if unrepaired or misrepaired. The complexity of 
composition at these breaks renders them more resistant to repair by NHEJ, which tends 
to ligate simple double-strand breaks spontaneously. One such structural hindrance is 
posed commonly by the presence of oxidized bases at or near the end of the DNA 
strands. Oxidized bases are a common result due to energy transfers and radiolysis 
during irradiation or internal metabolic processes. Since the production of these lesions 
in isolation is robust even during normal metabolism,  there is a highly evolved Base 
Excision Repair (BER) pathway that executes the repair of oxidized bases, with a minor 
contribution from other repair pathways such as NER (David, O’Shea, & Kundu, 2007). 
Nonetheless, when oxidized lesions are complexed with DNA double-strand breaks, there 
will be an interplay between NHEJ and BER. To evaluate the interference of these lesions 
with NHEJ, DSB’s substrate with partially complementary (–ATG and –ACA) 3′ overhangs 
with oxidized bases, either 8-oxo guanine (8-oxoG) as a terminal base or Thymine glycol 
(Tg) as a penultimate base were analyzed for end joining. These studies revealed Tg as 
a substantial hindrance to gap-filling and hence the end joining (R.-Z. Zhou et al., 2008b). 
Other studies have also shown Tg as a lethal modification in contrast to 8-oxoG which 
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was mutagenic (Bellon, Shikazono, Cunniffe, Lomax, & O’Neill, 2009) (Pearson, 
Shikazono, Thacker, & O’Neill, 2004).  
               To further evaluate the influence of Tg on NHEJ, blunt-ended DSB substrates 
were designed. These substrates were internally radiolabeled, and have Tg at different 
positions near one of the ends as shown in the Fig. 4.1. These blunt DSB’s were tested 
in cell extracts and recombinant protein assays.  An increase in the end-joining was 
observed with the increase Tg position from the double strand break (Tg3>Tg2>Tg1) 
(Mohammed Almohaini et al., 2016). Surprisingly, a reduced end-joining substrate with 
Tg placed at the fifth position was observed compared to Tg at the third position (10% vs. 
14%) (Fig. 3.2 lane 1 vs. lane 3). Also, there was the appearance of an extra band 
corresponding to the length of either 3-nucleotides (16-bp, lane 3) for Tg3 or 5 nucleotides 
(14-bp, lane 1) for Tg5, lesser than the usual unjoined (19-bp) band, suggesting removal 
of the Tg from the substrates. Further, the intensity of this band differed vastly for these 
substrates, Tg3 - 7.6% vs. Tg5 - 48.5% (lane 3 vs. lane 1).   Formation of this smaller 
fragment was almost instantaneous for Tg5 substrate.  
        This disparity in the end joining and the production of the smaller fragments can be 
explained by the attempted repair of the substrates by BER interfering with the end-joining 
process (Fig. 4.3). The recombinant protein assay with NHEJ core proteins confirmed this 
by showing an increased end joining in Tg5 substrates in comparison with Tg3 (7.2% vs. 
3.3%). When the Klenow Exo- polymerase enzyme was used on the substrate incubated 
for either 5 min, before it was digested, there was the conversion of almost all the 14-bp 
fragment to 19-bp or 20-bp (due to the addition of one extra-base by the enzyme) at 5 
min time point. However, substrate incubated for 6 hr showed the addition of bases 
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between 14-bp to 20-bp suggesting a nucleolytic degradation of the 5′ overhang of the 
complementary strand with time leading to the failure of the end joining of Tg5 substrate. 
To verify if the interference with NHEJ by BER is dependant on the position of Tg in the 
substrate, one of the major DNA glycosylases, hNTH1, which targets oxidized pyrimidine 
lesions, was tested on the Tg DSB substrates. 
 4.1 Recombinant protein hNTH1 activity on 3′ Tg substrates:  
There are various enzymes in place to remove and repair the damaged base in base 
excision repair. DNA glycosylases, monofunctional and bifunctional excise the damaged 
base in a lesion and function specific manner. Oxidized pyrimidines are resolved by two 
specific enzymes: endonuclease III (EcNth) and endonuclease VIII (EcNei) in E.coli,  and 
by their human orthologs hNTH1 and hNEIL1 (Bandaru, Sunkara, Wallace, & Bond, 
2002). In the previous experiments using 3′-Tg substrates, EndonucleaseIII was 
successfully used to remove thymine glycol (M. Almohaini et al., 2016). Therefore, in the 
current experiments, we used recombinant hNTH1 protein (provided by David Pederson, 
University of Vermont) to assay the removal of Tg from the substrates in extract-free 
reactions (Fig. 4.1). Initially, hNTH1, at a concentration of 840 nM was added to the 
reactions containing the different Tg substrates separately to evaluate the substrate 
specificity. Only Tg3 and Tg5 substrates were susceptible to the removal of Tg and not 
Tg1 or Tg 2 substrates. In correlation with the extract assays, Tg5 was processed robustly 
(79.6%) releasing a product corresponding to 3′-deoxyribose phosphate (dRp)-terminated 
14-bp.  As expected,  the Tg3 was minimally processed with 20.5% of 3′- dRp terminated 
16-bp. There were small amounts of 3′-phosphate termini for both the substrates (16P 
and 14P). On further treatment of the substrates with TDP1 enzyme, which is capable of 
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cleaving various 3′-blocks  (Nilsen et al ., 2012),  most of the 3′-dRp-terminated termini 
were converted to 3′-phosphate termini. 
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A. 
 
 
 
B.  
 Unmodified         Tg1              Tg2      Tg3         Tg5        Substrate 
 
 
 
  
 
 
Fig. 4.1: Recombinant hNTH1-mediated processing of 3′-proximal Tg substrates: A. 
Illustration of the ends of different Tg substrates. B. Individual substrates were treated 
with 840 nM hNTH1 for 1 hr and then with 10 µM TDP1 for 1 hr before NdeI cleavage and 
gel electrophoresis. As observed in the above gel picture Tg5 was more susceptible to  
cleavage by hNTH1 than Tg3 (lane 20 vs. lane 16). Figure adapted with permission from 
M. Almohaini et al., 2016. 
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4.2 Concentration-dependent kinetics of hNTH1:  
hNTH1 enzyme was titrated at different concentrations to measure the kinetics of activity 
as a function of concentration. When Tg3 and Tg5 were incubated in reactions with the 
increasing amounts of hNTH1, there was a steady and rapid increase in processing of 
the Tg5 substrate. Even though an increase in Tg3 processing was also observed,  it was 
less effeciiently processed than Tg5. Percentage of removal of Tg was plotted as a 
function of hNTH1 concentrations in Fig. 4.2B. While the total processing of Tg3 substrate 
was 78 ± 1.2%, Tg3 processing was 24 ± 0.42%. These observations suggest that Tg at 
the fifth position is a better substrate than at the third position for the BER. Further, when 
TDP1 was added to the reaction, there was a visible cleavage of 3′-dRp for Tg5 substrate 
as shown in the leftmost lane of the Fig. 4.2A. This extensive excision of Tg5 substrate 
by base excision pathway in the extracts might have compromised end-joining of the 
substrate. 
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Fig. 4.2: Purified hNTH1 mediate Tg cleavage from 3′-Tg3 and 3′-Tg5 substrates:  A. 
The Tg5 (left) and Tg3 (right) substrates were treated with the indicated concentrations 
of hNTH1 for 1 h, th cut with NdeI before denaturing gel electrophoresis. Additional 
treatment of the substrate with TDP1 removed the 3′‐dRp as shown in the leftmost lane 
in Tg5 processing. B. Comparison of Tg cleavage for the Tg3 and Tg5 substrates as a 
function of hNTH1 concentrations. Figure adapted with permission from M. Almohaini et 
al., 2016. (n = 3) 
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4.3 Effect of 5′-end Tg in end-joining of blunt double-strand breaks (DSB):   
                     Since the experiments with the substrates possessing Tg at various 
positions at the 3′ blunt end have given interesting results, we pursued the same 
experiments with substrates having Tg at the 5′ of the blunt end at either second (5′-Tg2) 
or a third position (5′-Tg3). Unlike the previous substrates which were labeled internally 
on 3′-strand, the 5′-substrates were radiolabeled at the 5′-terminal phosphate. Therefore 
loss of radioactivity as a result of processing in the cell extract experiments was a sign of 
Tg cleavage. These substrates were incubated in Bus cell extracts with (Fig. 4.3) and 
without XLF (Fig. 4.5)  for 6 hours and processed similarly to that of 3′-Tg substrates. 
           Upon incubation, there was a discernable amount of end-joining for both of these 
substrates as evidenced by the radioactive Head-to-Tail end-joining (38-bp) fragment on 
the gel. This was in contrast to the absence of any end-joining for the 3′-Tg2 substrate, 
and was only two-fold different from the 5′-Tg3 end-joining, 7 ± 1.2% vs. 12 ± 2.7% (Fig. 
4.3 B lane 5 vs. lane 7), considering its proximity to the ends. These results suggest   
compatibility of 5′-Tg, even when at the second position, for the Head-to-Tail end-joining 
as evidenced by the retained radioactivity. Further, there was no Head-to-Head end joing 
(36-bp) of these substrates, probably due to the strong hindrance of Tg presence at both 
the ends of DSB. However, there was a smaller amount of 22-25-bp end joining products 
(lane 5 and lane 7) for both the substrates probably due to a possible induction of 
resection at one of the ends owing to the presence of Tg at both the ends, with intact one 
end preserving the radioactive label.  Nonetheless, there appears to be retention of most 
of the radioactivity for both the 5′-Tg substrates as seen by the similar intensity of bands 
collectively in both cells extract free (Fig. 4.3B lane 3, and 5)  (Fig. 4.6A lanes 4 and 7) 
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and added samples (Fig. 4.3B lanes 4 and 6 ) (Fig. 4.6A lanes 5,6,7 and 9 ), suggesting 
a less removal of Tg relative to 3′-analogs.    
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Fig. 4.3: Effect of 5′‐proximal Tg on NHEJ in Bus cell extracts with XLF: Substrates 
with Tg as the second or third base from the 5′ terminus at the blunt labeled end were 
incubated for 6 h in XLF-complemented Bustel extracts. A)  Illustration of the substrates 
and head-to-tail ligation products. B. Denaturing gel analysis of end joining products 
following cleavage with NdeI and PstI is expected to release 38-bp Head-to-Tail, and a 
36-bp Head-to-Head end joining products. C. Plot of  percentage of Head-to-Tail products 
observed for the substrates. Figure adapted with permission from M. Almohaini et al., 
2016. (n = 3) 
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4.4 Susceptibility of 5′-Tg substrates to processing by recombinant hNTH1:  
Similarly to the 3′-Tg substrates, the 5′-Tg substrates were treated with increasing 
concentrations of pure protein hNTH1. The release of radioactive fragments was 
monitored to measure the function of bifunctional DNA glycosylase. As observed in Fig. 
4.4A, there was concentration-dependant release of radioactive fragments from both the 
substrates suggesting a Tg cleavage. Maximum release of radioactivity from both of these 
substrates by 840 nM hNTH1 was found to be similar (~60%). On comparison, excision 
of Tg from the 5′-Tg substrates was lesser than the 3′-Tg5 substrate but was higher than 
the 3′-Tg3 substrate (Tg3- ~30%, Tg5- ~80 %, and 5′-Tg2 and 5′-Tg3- ~60%). Total 
cleavage from both the 5′-Tg substrates is similar. 
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Fig. 4.4: Processing of substrates containing terminally labeled 5′-Tg to by purified 
hNTH1: A) The 5′-Tg2 (top) and 5′-Tg3 (bottom) substrates were treated with the 
indicated concentrations of hNTH for 1 hr and analyzed on a 36% nondenaturing gel for 
the release of the 5′-terminal nucleotide-ribose phosphate from the plasmid substrate. B) 
The release of the 5′‐terminal 1- or 2-base fragment measured as a percentage of 
radioactivity released into the gel from the well and plotted as a function of NTH1 
concentrations. Figure adapted with permission from M. Almohaini et al., 2016. (n = 3)   
B. 
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4.5 Validation of the above-observed results in cancer cell extracts: 
 Irradiation is one of the primary treatment modalities used to kill cancer cells, because of 
its capacity to cause enormous damage to cellular components, especially DNA. As with 
the normal cells, even cancer cells resort to repair these lesions by the retained repair 
pathways. To evaluate the repair of Tg lesions in cancer cells, all the above-mentioned 
substrates were processed in HCT116 colon carcinoma cell extracts. 
4.5.1 Processing of the 3′-Tg lesions in HCT116 extracts:   
The 3′-Tg substrates were incubated in HCT116 extracts for 6 hours before being 
proteolyzed, ethanol precipitated and treated with restriction enzymes NdeI and PstI (Fig. 
4,5). Repair of the substrates in the cancer cell extracts followed a similar trend of end-
joining (Tg3>Tg5>Tg2>Tg1) and BER (Tg5>Tg3), as in non-cancer fibroblast cell 
extracts, but with a lesser percentage end-joining compared to that of in Bus cell extracts 
(Fig. 4.5 vs. Fig. 3.4).  There was a formation of the BER product for Tg3 (16-bp) (lane 8) 
and Tg5 (14-bp) (lane 10), similarly to Bus cell extracts. As with the Bus cell extracts, Tg5 
is processed greater (~22%) than the Tg3 substrate (~4.8%) by BER. And also, this 
extensive processing by BER has reduced the Head-to-Tail end-joining of Tg5 substrates 
(~3%) compared to Tg3 end joining (~6%). The observed percentages Head-to-Tail end-
joining for all the substrates and the BER products of Tg3 and Tg5 substrates were plotted 
(Fig. 4.5 B) 
4.5.2 Influence of 5′-Tg on the repair of DSB’s in cancer cell extracts:  
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Similarly, the 5′-Tg substrates (5′-Tg2 and 5′-Tg3) were incubated in HCT116 extracts 
alongside the Bus extracts with or without substituted XLF. As seen in the radiograph of 
the gel (Fig. 4.6), there was lesser end-joining of these substrates in HCT116 extracts 
than in Bus extracts + XLF ( Fig. 4.6 lanes 4,5,6 vs. 7,8,9). There was more end joining 
(1.5 X) of the 5′-Tg3 compared to 5′-Tg2 substrates (Fig. 4.6 B) and corroborating the 
findings from Bus cell extract experiments. 
These results prove that irrespective of the origin of the cell, the Tg lesions formed in the 
promiximity of DSB’s are similarly susceptible to processing. Furthermore, the extensive 
processing mediated by BER can interfere with the end joining. 
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Fig. 4.5: HCT116 cell extract assays with 3′‐proximal Tg substrates: A) Each of the 
3′-Tg  substrates were incubated for 6 hr in extracts of HCT116 cells. B)  End-joining as 
well asTg cleavage, indication of BER were analyzed and plotted. Incresed formation of 
BER product is detected with less end joining for Tg5 (lane 10) compared to Tg3 (lane 8). 
Figure adapted with permission from M. Almohaini et al., 2016.   
A. B. 
C. 
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Fig. 4.6 Effect of 5′‐proximal Tg on NHEJ in Bus cell extracts with XLF: A. The 5′-
Tg2 and 5′-Tg3 substrates were treated with HCT116 whole cell extracts (lanes 7-9), in 
addition to Bus extract with (lanes 4-6), and without XLF (lanes 1-3),  for 6 hours. B. The 
percentage of Head-to-Tail end joining was measured and plotted. (Tg0 = unmodified 
ends) 
 
 
 
   
B. 
A. 
 
 
Extracts 
5′ Tg substrates 
1 2  3  4  5  6       7 8 9       10 
  
N
o
 e
x
tr
a
c
t 
58 
 
 
On the whole, repair of complex lesions, especially those involving strand breaks pose a 
complicated scenario requiring an interplay between multiple repair pathways to resolve 
the lesion to avoid lethality. It can be hypothesized that in cells there could have been 
end-joining of the Tg5 substrates by the resection dependant late NHEJ or alternative 
end-joining pathway (Alt-NHEJ) and if progressed to G2, repaired by Homologous 
recombination. However, in our extracts when we tried to sequence the end-joining, there 
was no evidence of deletions or insertions at least in the 20 samples screened. There can 
be two possible reasons for this. The end-joining in these samples was allowed to 
progress only for 6 hr and the other processes mentioned above takeover after 6-8 hr.  
Moreover, since the experiments were done in a cell-free extract, it might not be possible 
to replicate all of the processes occurring in the cells, with a limitation of the activation 
and availability of other factors. 
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                                                 V. Discussion 
 
 Oxidative lesions are one of the most common lesions due to radiation, DSB’s being the 
lethal amongst them,  more so if accompanied by a modified or complex lesion at the 
ends. Further, BER enzymes can convert readily repairable or bypassable lesions into 
lethal while processing bistranded damage clusters (Harrison, Hatahet, Purmal, & 
Wallace, 1998). Radiation can produce strand breaks accompanied by damaged/oxidized 
bases. Most commonly oxidized bases are Guanine to 8 –oxo-guanine (8 oxo-G) and 
Thymine to thymine glycol (Tg). Previous experiments with 8 oxo-G have suggested it to 
be least tolerant when placed at the DSB, at least 4 bases from a 3′end or 6 bases from 
a 5′end and when two 8-oxoG lesions are positioned across the break junction, ligation is 
severely retarded (Dobbs, Palmer, Maniou, Lomax, & O’Neill, 2008). In the current study, 
we wanted to research the tolerability of Thymine glycol at the blunt double-strand break.                     
Thymine glycol (5,6-dihydro-5,6-dihydroxythymine, Tg), a prototypic pyrimidine lesion 
arises from reactive oxygen species attacking either thymine or methyl cytosine. Tg is a 
common product of endogenous metabolism, chemical oxidation, or ionizing radiation 
(Cathcart, Schwiers, Saul, & Ames, 1984).  Unlike 8-oxo-G, the most common purine 
oxidative lesion which was shown to be mutagenic, Tg is a  lethal lesion as it blocks the 
replication. Due to its non-planar structure, the base becomes extra-helical hindering the 
stacking of the next 5′ templating residue and inhibiting the next incoming nucleotide, 
effectively blocking conventional polymerase-mediated DNA replication. (Robert C. 
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Hayes & Leclerc, 1986). However, polκ/polζ and polθ mediate alternate pathways for 
promoting replication through a Tg lesion. In the polκ/polζ pathway, following the insertion 
of an A opposite TG, polζ would extend from the TG: A base pair. On the other hand, polθ 
carry out both steps of TLS, generating ∼5% mutationally altered TLS products (Yoon, 
Roy Choudhury, Park, Prakash, & Prakash, 2014). Repair of the thymine glycol lesion 
can be by BER, NER and transcription-coupled repair (TCR), hNTH1 and hNEIL1 of BER 
playing a major role in excising Tg (Dolinnaya, Kubareva, Romanova, Trikin, & Oretskaya, 
2013b).  
    The current study is an extension to previous observations made in the lab by 
Mohammed et al., 2016, positioning Tg at different lengths from the 3′ end of the blunt 
double-strand break and study it in the context of NHEJ. It was noted that Tg placed at 
the third position allowed for an efficient end-joining compared to the first and second 
positions. However, placing Tg at fifth position limited the end joining while producing a 
more evident smaller fragment of DNA corresponding to a cleaved product at the Tg.  Tg 
is a substrate for two BER repair proteins hNTH1 and NEIL1, which removes the lesions 
via β-elimination or β,δ-elimination respectively. Although these proteins can backup each 
other, they are expressed in a tissue-specific manner (Hazra et al., 2002) (Aspinwall et 
al., 1997). To support our hypothesis that there is more base excision repair of Tg5 
substrate hindering the end-joining, a pure recombinant NHEJ protein assay was done. 
In the absence of other repair factors, we evidenced an increase in the end-joining of Tg5 
substrate compared to Tg3 substrate. Further, we wanted to see if Tg5 was a better 
substrate than Tg3 for BER by performing a recombinant protein assay with hNTH1. As 
expected,  hNTH1 repaired Tg5 more efficiently compared to Tg3. 
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                      Next preference of positioning Tg at 5′end for BER was measured by 
positioning Tg at the second or third position of the blunt DSB. There appeared to be no 
preference in overall processing these substrates.In contrast to the internally labeled 3′ 
substrates, 5′ substrates are terminally labeled, and the end-joining of these substrates 
was evident from the detection of the band which was about 40% and 60% of the 
unmodified substrate end-joining for Tg2 and Tg3 respectively. Unlike 3′-Tg at a second 
position which allowed for minimal end-joining,  5′-Tg at second position allowed for 
considerate end-joining, with Tg in position.  
             All the above experiments were performed in Bustel fibroblast extracts which are 
inherently deficient in XLF, an end-joining protein, to study its role in NHEJ. To validate 
the observations made in these extracts and also to study the repair of Tg lesions in 
cancer cells which could be a result of radiotherapy, processing of Tg lesions was tested 
in HCT116 cell extracts. Even though the overall end joining seen in these extracts is less 
compared to Bus cell extracts, the profile of the repair of Tg lesions appeared to be similar.  
Extensive nucleolytic excision of the 5-base 5′-overhang of the complementary resulting 
from the BER might have limited the end-joining of the Tg5 substrates in both the extracts 
(Fig. 3.2 vs. Fig. 4.5). Similarly, there was appearance of the unjoined BER product of 
Tg3 in both the extracts. On the whole,  these studies provide evidence that both BER 
and NHEJ function hand in hand in the repair of oxidative lesions, with BER interfering 
with NHEJ in a lesion dependant manner. 
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Fig. 5.1:  Proposed model for the interference by BER in NHEJ : A) When base 
excision repair proteins recognize and remove the Tg from the third position in Tg3, 
instead of the 19- bp fragment 16-bp fragment was formed and there was no end joining 
of the fragments. B) When the Tg from the Tg5 substrate was removed, there was the 
formation of 14-bp fragment, and there was no end joining. 
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                                                                                Chapter 2 
 
 
RESOLUTION OF DNA 3′-PHOSPHATE ENDS IN THE ABSENCE OF PNKP AT THE 
FREE RADICAL-MEDIATED DNA DOUBLE-STRAND BREAKS FOR 
NONHOMOLOGOUS END JOINING 
                           
                                                      VI. Introduction 
 
                  A feature of ionizing radiation resulting from its mode of energy 
deposition is a generation of a high local concentration of free radicals producing complex 
DNA lesions, two or more lesions within 1–2 helical turns of DNA, which may involve 
strand breaks. DNA strand breaks are also a consequence of DNA damage due to 
chemotherapy, metabolic oxidative process or during repair of the complex lesions by the 
repair machinery. These strand ends are rarely clean with a variety of chemical 
modifications and are non-compatible for re-ligation. 3′- phosphate and/or 5′- hydroxyl 
ended SSB’s or DSB’s can be a direct result of the insult or as an intermediate during 
processing of the base damage or overhang 3′-phosphoglycolate end by NEIL enzymes 
and TDP1, respectively. PNKP is a bi-functional enzyme with a DNA 5′- kinase and 3′-
phosphatase function that restores the strands conventional compositions –i.e., a 3′-
hydroxyl and 5′- phosphate ends.PNKP was the first gene for a DNA-specific kinase from 
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any organism and the second gene for a mammalian DNA 3′-phosphatase to be identified 
(Jilani et al., 1999) PNKP plays a crucial role in processing both single strand, and double 
strand breaks, enabling them to be filled in and ligated by DNA polymerases and DNA 
ligases, respectively. Because of its ubiquitous role in repair of the DNA, PNKP is being 
considered as a potential target for chemotherapy. Stable down-regulation of PNK in 
human cells results in hypersensitivity to a number of DNA damaging agents including 
ionizing radiation, camptothecin, and H2O2 and also increases the spontaneous mutation 
frequency (Rasouli-Nia, Karimi-Busheri, & Weinfeld, 2004). Studies have also shown that 
PNKP’s role as a party of NHEJ is essential for the normal neurological development of 
the organism (Dumitrache & McKinnon, 2017) (Bras et al., 2015) (Reynolds, Walker, 
Gilmore, Walsh, & Caldecott, 2012). These studies showed that knockout of PNKP 
resulted in lethality while the mutations induced developmental delay of the CNS. 
6.1 Polynucleotide kinase phosphatase 
6.1.1 Structure: 
The domain-mapping experiments, sequence analysis, and crystallography studies have 
revealed a three domain molecular structure - Kinase, Phosphatase and Fork Head 
Associated domains (FHA) for the PNKP protein. The phosphatase (Gly 145–Glu 336) 
and the kinase (Phe 340–Glu 521) catalytic domains are linked flexibly to an 
aminoterminal phosphoprotein-binding forkhead-associated domain (Ser 6–Ser 110)   
(Bernstein NK et al., 2005).  This flexible organization of the FHA and catalytic domain 
was revealed by the trypsin digestion which releases a 40 kDa (catalytic domain) and 14 
kDa FHA domain. The interdomain linker (Leu 337–Ala 339) and the C-terminal residues 
Gln 518–Gly 522 pack against helix 5 and the β12-α4 loop of the phosphatase prohibiting 
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the separation by proteolysis.  The phosphatase domain which encompasses 136 to 337 
residues has a  structure typical of the haloacid dehalogenase (HAD) superfamily, which 
includes β-phosphoglucomutase (β-PGM), phosphoserine phosphatase (PSP), P-type 
ATPase and RNA polymerase II CTD phosphatase (Aravind, Galperin, & Koonin, 1998). 
Although there is low sequence similarity between these proteins, there is a conserved 
motif Dx(D/T)x(T/V), where the first Asp (170 in mPNK) forms the covalent 
phosphoaspartate intermediate. Serine or threonine (216), a lysine (259), and a pair of 
aspartates (288 and 309) are the other conserved residues, all of them located in the 
HAD α/β domain (Bernstein NK et al., 2005). Despite structural variations among the α/β 
domains, the active site configuration is exquisitely preserved.   
                The kinase domain is of  189 residues and belongs to the adenylate kinase 
family and consists of a 5-stranded parallel β sheet, common to GTPases and P loop 
kinases (Leipe, Koonin, & Aravind, 2003) (Leipe et al., 2003), and is flanked by helices 
on both sides. Also, there are three helices (α12, 13, and 15) which lie between the α/β 
sandwich and the phosphatase domain. The kinase active site is located in a long cleft 
and similar to other ATP binding sites, it has a conserved Walker A and B motifs.  The 
protein-phosphoprotein interaction motif, FHA,  has a high specificity for 
phosphothreonine (pThr) residues. Structurally, it possesses the typical β sandwich fold 
consisting of a 3-stranded and a 4-stranded antiparallel β sheets. The N- and C termini 
of the domain are located on adjacent β strands, and loops bind the phosphopeptide on 
the opposite side of the domain. There is a  conserved motif S47RNQ50 that forms a 
protruding U-turn shape preceding the β5 strand, and the recognizes of phosphopeptide 
by a conserved Arg (Arg70) and Ser (Ser85) residues and nonconserved Arg48 residue. 
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Among the domains of the protein, FHA domain is poorly ordered, allowing for the 
flexibility of the catalytic domain. 
6.1.2 Substrate specificity, recognition, and function of PNKP: 
Each catalytic domain has its preference for the substrate. The kinase domain of PNKP 
preferentially phosphorylates the 5′ end of DNA at the nicks and small gaps (Karimi-
Busheri & Weinfeld, 1997) and a duplex of at least 8 nucleotides with a 3′-overhang of ≥ 
three nucleotides (Bernstein et al., 2009).  The kinase active site located in the deep cleft 
with ATP binding site on one side and the DNA substrate binding site on the other. The 
substrate binding site has two positively charged surfaces, one flanking the Asp 396, 
which acts as a general base to activate  5′-OH group in the duplex. The phosphate group, 
3′ to the 5′OH end, is stabilized by Thr 423, and no contact is made with the protein by 
the substrate until 6-8 nucleotides on the complementary strand upstream around Arg 
403, consistent with the substrate requirement. The other side of the cleft surface consists 
of Arg482 and Lys483 which interact with the four backbone phosphate groups of the 
single-stranded 3′ overhang downstream of 5′ OH strand, explaining the minimal length 
requirement for the 3′ overhang.The Aspartic 396  interacting with the 5′-OH group of the 
substrate forms general base assistance for the nucleophilic attack on the ATP γ-
phosphate, with the aid of Mg2+, resulting in the phosphorylation of the 5′-end.  
                   In contrast to the kinase domain, the phosphatase domain accepts a broad 
range of substrates including nicked, gaped DSB and oligonucleotides of short segments 
5′ to the 3′-phosphate. The phosphate group at the active site in the conserved motif 
Dx(D/T)x(T/V), is stabilized by, Mg2+, Lys 259, Thr 216 and main chain NH of Leu171. 
There is an in-line nucleophilic attack on Asp170 producing a phospho-intermediate and 
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a leaving group. The release of phosphate from the phosphointermediate is catalyzed by 
Asp 172 which functions as a general acid by protonating the alcohol leaving the group 
(Bernstein et al., 2008). However, the narrow, deep active cleft can accommodate only 
single but not the double strand substrates. To access the phosphate group in double-
stranded substrates, PNKP needs to unwind the DNA with the help of its conserved basic 
surface. While the Phe 184 forming “the Phe wedge,” plays a critical role in the initiation 
of base-pair destabilization through hydrophobic interactions with the substrate bases, 
Phe305, buried in the active site, could play a role in stabilizing the liberated single-strand 
in the catalytic conformation through stacking interactions with the 3′-terminal base. 
Recognition and interaction of the penultimate base are also crucial for binding and 
activity of the enzyme.  Lys184 and  β13-α6 loop (residues 300–303), away from the 
active site engage with the partner strand in the double-stranded substrate before 
destabilization, providing additional binding energy, and with the complementary 
undamaged strand after base-pair destabilization. This stabilization of the complementary 
strand is required to compensate for the unfavorable free energy associated with base-
pair disruption (Coquelle, Havali-Shahriari, Bernstein, Green, & Glover, 2011). 
Fluorescence Spectroscopic Studies of 2AP-Modified DNA Complexes have shown that 
the destabilization of the double-stranded DNA substrate was maximum up to 2 terminal 
bases with partial destabilization up to 8 terminal bases (Coquelle, Havali-Shahriari, 
Bernstein, Green, & Glover, 2011). The FHA domain of the PNKP recognizes the CK-2 
phosphorylated phosphothreonines on  XRCC1 and XRCC4, directing PNKP towards 
either single strand or double strand breaks, respectively.  
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                       The phosphatase activity of the enzyme takes precedence over and has a  
faster catalytic rate than kinase activity (Dobson & Allinson, 2006). This precedence of 
phosphatase over kinase activity may be due to protecting the DNA from the most 
common damage induced by radiation or by bifunctional glycosylases, i.e., 3′-phosphate 
formed more commonly than the 5′-hydroxyl ends.Given the limited flexibility between the 
catalytic domains, there is a sequential repair of the DSB substrates having to possess 
both 3′-phosphate and 5′-hydroxyl ends. There are a preferential binding and processing 
of the 3′-phosphate, kinase activity being almost stoichiometrically inhibited by the 3′-
phosphorylated competitor (Dobson & Allinson, 2006). There appears to be interdomain 
cross-talk between the two active sites since the ablation of the 3′-phosphatase activity 
blocks the 5′-kinase activity.  Presence of a 3′-phosphate end prevents phosphorylation 
at the 5′-end and premature conversion to 5′-phosphate end, which would result in an 
abortive ligation attempt by the DNA ligases adding an adenylate group to the 
phosphorylated end (Ahel et al., 2006a). Further, the presence of a 5′-hydroxyl block can 
be theoretically bypassed by extending the 3′ hydroxyl strand and by the removal of 5 
hydroxyl flap by FEN, which leaves a 5′ phosphate, allowing for the successful ligation 
(Dianov, Sleeth, Dianova, & Allinson, 2003). 
6.1.3 Role of PNKP in strand break repair:  
For ligation and extension of the of the DNA ends, 3′ hydroxyl and 5′-phosphate ends are 
imperative. PNKP’s function as a DNA 3′-phosphatase is crucial in achieving the strand 
integrity. Hence, PNKP participates in repairing various SSB’s/DSB’s caused due to drugs 
such as Bleomycin,  during BER, and NHEJ. Depending on the repair pathway, PNKP is 
seen to interact with various proteins in the repair complex. In NHEJ, PNKP is shown to 
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form a complex with XRCC4 in dual modes, with non-phosphorylated via FHA domain or 
phosphorylated (pXRCC4 via the catalytic domain (Fig.5.1) Interacting with XRCC4 alone 
enhanced the 5′ kinase activity on the DNA ends, only to be slightly increased by 
XRCC4/LigaseIV. However, interacting with pXRCC4 inhibited the activity which was 
reversed by the pXRCC4/LigaseIV complex (Mani et al., 2010a). Small angle X-ray 
scattering (SAXS) structural studies have shown that there is flexible tethering of PNKP 
to XRCC4 via the FHA-phosphopeptide interaction, adopting a compact conformation 
which allows for the dynamic interaction between the PNKP catalytic domain and the N-
terminal structured region of XRCC4 and/or the LigIV BRCT domain (Aceytuno et al., 
2017a). Depriving of this later interaction due to an E326K mutation in human cells 
reduces PNKP recruitment to sites of UV laser-induced DNA damage and is associated 
with a severe form of the neuro-developmental disorder termed MCSZ (Shen et al., 2010). 
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Fig. 6.1: PNKP structural representation: A. Ribbon diagram of mammalian PNKP with 
kinase domain represented in yellow, phosphatase in blue and FHA domain in green, with 
ATP binding P-loop in navy blue. Figure adapted with permission from Bernstein et al., 
2005. B. Schematic representation of PNKP domains with labeled XRCC4/XRCC1 
interacting regions on PNKP. Figure adapted with permission from                                                                                                                                                                 
Allison 2010. 
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                                                             Hypothesis 
 
 
There are alternatives to Polynucleotide kinase phosphatase enzyme (PNKP) which can 
process DNA 3′-phosphate and 5′-hydroxyl ends in its absence 
 
 
Background: 
PNKP enzyme converts DNA 3′-phosphate and 5′-hydroxyl ends to 3′-hydroxyl and 5′-
phosphate ends, enabling strand extension and/or ligation. . There has been no other 
factor identified to compensate for the loss of PNKP. However, when PNKP was 
knockdown or pharmacologically inhibited there was no difference in processing of the 
DNA 3′-phosphate ends produced by treatment of HCT116 cells with Neocarzinostatin 
(NCS), as detected by Ligation-mediated PCR (LM-PCR). Therefore, to further study the 
effects of loss of PNKP, PNKP knockout cells were used to study processing of the 
specific substrates, in the context of NHEJ, in the extracts. Also, we also elucidated the 
role of core NHEJ factors in the processing of these substrates.   
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6.2 Specific aims:  
 
 
1: To evaluate the processing of DNA 3′-phosphate DSB substrates in wild-type and 
PNKP knockout extracts to determine whether there are alternative DNA 3′-
phosphatases and whether they function in the context of NHEJ  
 
2: To identify the presence of DNA 5′-kinases in the HCT116 PNKP knockout extracts 
 
3: To determine the role of XRCC4 and XLF in processing DNA 3′-phosphate and 5′-
hydroxyl substrates 
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                                                              VII. Material and Methods 
 
7.1 3′-phosphate substrate 
Oligonucleotides with 3′-phosphate, 3′-phosphotyrosyl ends, and 5′-hydroxyl ends are 
acquired from Midland labs (Texas). They were re-suspended in TE (10 mM Tris–HCl, 
pH 8, and 0.1 mM EDTA). 1 mCi of [γ-32P] ATP was used to label 50 pmoles of the 
oligonucleotide, using Polynucleotide kinase (PNK) and incubated for 1 hr at 37 °C.   
7.2 Preparation of pRZ56 and ligation of oligomers to the MluI cleaved pRZ56 
The polylinker region of pSV56 plasmid was excised as a 625-bp PflMI/AvrII fragment, 
and cloned into pBR322 between the EcoRV and NheI sites (the PflMI cut was blunt-
ended with T4 polymerase), to create a 5-kb pRZ56 plasmid. 76 μg of the plasmid pRZ56 
DNA was linearized with 100 units of MluI (NEB) in 0.3 ml of NEB buffer 3 for 2 hr at 37 
°C and was ethanol precipitated. 10 μg of the linearized plasmid was then subjected to 
controlled 3′ → 5′ exonucleolytic digestion with five units of T4 polymerase (NEB), 1 mM 
dTTP in a buffer containing 33 mM Tris-acetate pH 8, 66 mM potassium acetate, 500 μM 
DTT 100 μg/ml BSA at 11 °C for 2 hr. The plasmid was proteolyzed and ethanol 
precipitated and resuspended in 40 μl TE after drying.  This procedure results in a 10-
base 5′ overhang at one end and an 11-base 5′ overhang at the other due to resection at 
each 3′-terminal strand to the first thymine in the sequence. 5 picomoles of an unlabeled 
13-mer and a 5′-32P-labeled 14-mer with a 3′-phosphate, or an unlabelled 9-mer and a 5′-
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32P-labeled 10-mer with a 3′-phosphate or an unlabeled 13-mer and a 5′-32P-labeled 14-
mer with a 3′-phosphotyrosyl, each complementary to its 5′ overhangs, were successively 
ligated with 60 units of T4 DNA ligase, in 1X Ligase buffer in a 50 μl reaction for overnight 
at 16 °C to  specifically labeled substrates with partially complementary (-ACG) overhangs 
or recessed ends. These substrates were purified on a 0.8% agarose gel, electroeluted 
and concentrated with an Ultracel 100k centrifugal filter.  
7.3 Construction of 5′-hydroxyl substrates:   
5′-CCGGGGACCTGCGTACGTGTTC and 3′-CCTGGACGCATGCAC-OH, 
complementary oligonucleotides were ordered from Midland Labs, Texas and re-
suspended in TE (10 mM Tris–HCl, pH 8, and 0.1 mM EDTA). They were annealed in 
equal quantities, via heating to 80 °C followed by slow cooling to 10 °C. The duplexes 
generated by this annealing process resulting in 3-base 3′overhang on one end with a 5′-
hydroxyl group in the complementary strand, and a 4-base 5′ overhang on the other end 
that is complementary to the 5′ overhang created by XmaI digestion of pUC19.   
7.4 Ligation of oligomeric duplexes to the XmaI cleaved pUC19: 
20 μg of the pUC19 plasmid DNA is digested with 100 units of XmaI (NEB) in 0.7 ml of 
NEB Cut Smart buffer for 3 hr at 37 °C. 7 μg of the cut plasmid is treated with 10 units of 
CIP in 2.4 μl of CutSmart buffer for 1 hr at 37 °C in a total reaction volume of in 20 μl. The 
linearized fragment was ethanol precipitated and was radiolabeled with 6 μl 1 mCi γATP 
and 3 units of T4PNK for 45 minutes in 37 °C, which was ethanol precipitated again. The 
precipitate was dissolved in 40 μl of TE, and to this, 20 μM, oligo duplex with 5′-hydroxyl 
end was ligated with 800 units of T4 ligase in 5 μl of T4 Ligase Buffer, in a total reaction 
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volume of 50 μl, at 16 °C overnight. The resulting substrate had two recessed 5′-hydroxyl 
ends and labeled on both ends.The ligation products were purified by 0.8 % agarose gel 
electrophoresis and Electroelution.          
7.5 Electroelution of the modified substrates: 
The nucleotide is electroeluted using an 11-inch segment of pretreated dialysis tubing 
(6,000-8,000 molecular weight) filled with the buffer composed of 20 mM Tris, pH8 and 1 
mM EDTA (the elution buffer). The gel slice containing the desired DNA band was placed 
in the dialysis tubing, and the other end of it was knotted after removal of air bubbles. The 
dialysis tube was placed in a gel box filled with the same buffer, and the DNA was eluted 
overnight at 50 V.  Then the dialysis bag was cut, and the buffer containing DNA substrate 
was collected into 15 ml centrifuge tubes. 0.45μm filters were used to remove any debris, 
and the DNA was concentrated by micro- concentration to about 500 μl using centricon-
100 (Amicon). The concentrate was collected into 1.5 ml Eppendorf tubes and 
precipitated with 1/9 volumes of NaOAc and 2.5 volumes of 100% EtOH, washed with 
70% EtOH and dissolved in 50 μl TE. 
7.6 HCT 116 and HeLa cell extracts preparation: 
 HCT116 and HeLa, Wildtype (WT) and PNKP CRISPR knockout cells (PNKP-/-), cells 
were kindly provided by Dr. Weinfeld, Cross Cancer Institute, Alberta, Canada. These 
cells were grown to 70% - 90% confluence on 15-cm dishes each with 15 ml RPMI media 
with 10% FBS. Then they are serum starved for 4 days with 15 ml of .5% serum. On the 
day of the experiment, the dishes were washed with 20 ml PBS at room temperature. 3 
ml of 0.25% trypsin-EDTA was added to each dish, making sure it covers all the cells. 
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They were incubated for 5 min until the cells are detached and then 3 ml medium and 
serum was added. These samples were collected and pelleted in 50 ml tubes at 1500 
rpm for 5 min in ultracentrifuge using SW55 rotor at room temperature. The cells were 
resuspended in 50 ml medium and serum and pelleted again. The pellet was again 
resuspended in 25 ml medium and serum and pelleted again. The pellet was 
resuspended in 30 ml ice-cold PBS and pelleted at 4 °C and packed cell volume (PCV) 
was recorded. The last process was repeated again. The pelleted cells were resuspended 
in 5XPCV cold hypotonic buffer containing10 mM Tris-HCl pH8, 1 mM EDTA, 5 mM DTT 
and proteinase inhibitors pepstatin 1 μg/ml, chymostatin 1 μg/ml, aprotinin 2 μg/ml, 
leupeptin 1 μg/ml, PMSF 1 mM.  The cells were quickly pelleted. This pellet was again 
resuspended in 2XPCV hypotonic buffer and inhibitors and let set on ice 20 min. 1.5 ml 
of this solution was put in a small dounce homogenizer each time and stroked 20 times. 
After it was let set for 20 min, it was transferred to cold 5 ml centrifuge and ¼ volume of 
the hypertonic solution ( 83.5 mM Tris pH 7.5, 1.65 M KCl, 3.3 mM EDTA, 1 mM DTT) 
and inverted several times to mix well. This was centrifuged at 43K for 3 hr in SW55 at 2 
°C. From the top the middle layer which has cytosol was collected using 22G needle, 
avoiding cloudy layer on the top. The cytoplasm thus collected was dialyzed for 3 hr in 
storage buffer (20 mM Tris pH 8, 0.1 M KOAC, 1 mM DTT, 0.5 mM EDTA, 20% glycerol) 
with inhibitors at 4 °C. The resulting solution was frozen in small aliquots(10 μl - 80 μl) at 
-80 °C. 
7.7 3′-phosphatase, 5′-kinase and end joining assays using cell extracts: 
 HCT116 Wildtype (WT) and PNKP knockout, HeLa Wildtype (WT) and PNKP knockout, 
Bustel whole cell extracts (with/without 200 nM recombinant XLF) and HCT116 XRCC4-
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/-, were used for the reactions in a buffer containing 50 mM triethanolammonium acetate 
(pH8), 1 mM ATP, 1 mM dithiothreitol, 50 μg/ml BSA , 1.3 mM Mg(OAc)2 and dNTPs at 
100 μM each. 
The total reaction volume was 16 μl, with 10 μl or 11.5 μl of extract, resulting in a final 
protein concentration of 12.5 mg/ml. 20 ng of the substrate was added and the reaction 
mixed by pipetting and incubated at 37 °Cfor various times as mentioned. In reactions 
with Bus cell extracts, 200 nM XLF was added to some reactions. XRCC4 knockout 
extracts were substituted with either 0.6 μg of pure XRCC4/LigaseIV or 30 ng of PNKP. 
In some reactions, the extracts were pre-incubated for 10 min with 0.2 μl DNA-PKcs 
inhibitor, NU7441, dissolved in DMSO, at the indicated concentrations. After certain 
incubation times, samples were deproteinized by adding an End Joining Lysis buffer 
containing, 1% SDS, O.3 M Nacl, 20 mM Tris HCL pH 7.6, 10 mM EDTA and 1 mg/ml of 
Proteinase K for 3 hr at 56 °C. The DNA was then precipitated with glycoblue and ethanol 
for one hour. After the precipitation, all samples were dissolved in 21 μl of TE and digested 
with 10 units of BstXI/AvaI and TaqαI and 2.5 μl of 10X CutSmart buffer (New England 
Biolabs) at 37 °C for 3 hr. Gel electrophoresis of the samples was done in 20% 
polyacrylamide sequencing gels. Then the gels were exposed to phosphoimaging screen 
for 1 or 2 days at -20 °C.  Data were analyzed using a Typhoon 9100 imager (GE 
Healthcare Bio-Sciences, Pittsburgh) and Image Quant 3.1 or 5.1 software (GE 
Healthcare Bio-Sciences, Pittsburgh). The percentage of 3′ phosphatase, 5′-kinase and 
end joining was determined by measuring the percentage radioactivity of the joined 
fragments as a function of total radioactivity in the same lanes 
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7.8 Nuclear and Cytoplasmic fractionation and Western blot:  
HCT116 and Hella cell extracts fractionation was done using a kit from Bio-vision. The 
protein in the extracts was quantified by BCA aasay and were normalized to the same 
concentration. Laemmli buffer (4% SDS, 20% glycerol, and 120 mM Tis pH 6.8, 10% 
BME)  was added to the extracts and boiled for 10 min at 90 °C. 50 μg of the protein from 
both the extracts were resolved on either a  10% or Any-KD Biorad SDS-Polyacrylamide 
gel. Pure PNKP protein, kindly provided by Dr. Weinfield was used as a positive control. 
PNKP in was detected by using  Mouse monoclonal antibody at 1:5000, against the 1 -
140 aa epitope (initially to define the knockout status). In the later experiments, 
membranes were probed with either a Mouse monoclonal antibody (Santa Cruz) with an 
epitope of aa 379-411 (1: 500) or Rabbit polyclonal antibody (1:10,000) (Dr. Weinfeld) 
raised for full-length protein. All the primarry antibodies were diluted in 1%Casein in PBS, 
added to the membranes incubated overnigt at 4 °C, with rocking. Ater washing the blots 
with TBST 10 minutes x 3, the membranes were incubated in 10 ml of respective 
peroxidase conjugated (chemiluminiscent) secondary antibodies, recombinant anti-
mouse antibody (Santa Cruz) at a concentration of 1:1000 and goat anti-rabbit (Cell-
signalling)  at a concentration of 1:3000,  in 1% Casein in PBS, for one hour at room 
temperature. After washing the membranes with TBST 10 minutes x 3, ECL Thermo-
scientific Fischer substrates were added to develop an X-ray or image using Biorad 
imager.Thermoscientific Fischer Supersignaling western blot enhancer kit was used for 
the antibody from Santa Cruz, to increase the sensitivity of detection. Image J was was 
used for the quantification of the bands. 
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7.9 Nuclear extract 3′-phosphatase reactions: 
Nuclear extracts of HCT116 and HeLa extracts were assayed for the phosphatase activity 
in a reaction similar to whole cell extracts, at 2 mg/ml concentration of nuclear protein and 
a buffer containing 50 mM triethanolammonium acetate (pH8), 1 mM ATP, 1 mM 
dithiothreitol, 50 μg/ml BSA , 1.3 mM Mg(OAc)2 and dNTPs at 100 μM each. 20 ng 3′-
phosphate overhang substrate was incubated in these reactions incubated at 37 °C for 
various times as mentioned, which were then proteolyzed, ethanol precipitated and cut 
with AvaI to be analyzed on a 20% PAGE. 
7.10  PNKP inhibitor assay: 
ST042146, a 3′ phosphatase inhibitor was dissolved in DMSO at a stock concentration of 
50mM and different dilutions of  10 mM, 1 mM, .4 mM and .1 mM were made in separate 
tubes. They were incubated overnight at 72 °C, which darkened the drug solutions. PNKP 
inhibition assays were performed on either a PNKP pure protein (100ng), or 1:125 
(HCT116) or 1:100 (HeLa) WT and PNKP knockout extracts diluted in PNKP storage 
buffer (50 mMol/L Tris-HCl (pH 7.4), 100 mMol/L NaCl, 5 mMol/L MgCl2, and 0.5 mMol/L 
DTT). 100ng of PNKP pure protein was added to a 20 μl reaction with 1X phosphatase 
buffer (50 mMol/LTris-HCl (pH 7.4), 0.01 mMol/L EDTA, 0.1 mMol/L spermidine and 2.5 
mmol/L DTT).  For the extract assays, the diluted whole cell extracts were added to the 
above phosphatase buffer in a total reaction volume of 16 μl. Before adding the 3′-
phosphate substrate to these extracts, the reactions were incubated with DMSO or 
ST042164 to a final concentration of  20 μM or 50 μM, for 10 min at 37 °C. 20 ng of the 
substrate was added to each of these reactions and incubation was continued for 1 hour 
at 37 °C. Later the samples were proteolyzed and processed similarly as above. 
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7.11 Polyacrylamide gel electrophoresis: 
For electrophoretic separation of the DNA strands, Polyacrylamide gels (20x30x0.08cm)   
containing 40% acrylamide: bisacrylamide in a ratio of 20:1, 8 ml of 10XTBE and urea in 
a final concentration of 8.3 M ina total volume of 80 ml, were used. The mixture was 
cooled to room temperature, and 0.06 g ammonium persulfate and 45 μl of TEMED (N’, 
N,’ N,’ N’-tetramethylethylene diamine) were added. The gel was allowed to polymerize 
for 1 hour. 15 μl of samples are then loaded into the wells of the gel and electrophoresed 
at a constant power of 42 W until the marker reached the bottom of the gel.          
7.12 Statistics: 
Error bars represent standard error of the mean (SEM) for at least two independent 
experiments. Unpaired two-tailed t-tests and ANOVA were performed as required and the 
data was reported as significant if p values <0.05. 
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Ajinkya Kawale 
Fig. 7.1: Western Blot confirming the PNKP knockout: WT and HCT 116 cell nuclear 
extract and cytoplasmic extracts were fractionated using BioVision Nuclear/Cytosol 
Fractionation Kit and were resolved on a 10% SDS-PAGE, which was botted on to a 
nitrocellulose membrane, and probed a mouse monoclonal antibody targetting aa 1-140 
on the N-terminal end and was detected using a secondary anti-mouse peroxidase 
labeled antibody. Vinculin was used as a loading marker for a cytoplasmic fraction, while 
the non-specific band in the nuclear extract fraction was considered as a loading control. 
As seen in the lane 2 from the left, there was no band corresponding to PNKP in the 
PNKP knockout nuclear extract 
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Fig. 7.2: Designing 3′-phosphate double-strand DNA break substrates: Illustration of the 
synthesis of a 3′-phosphate substrate by ligating different P32- labeled oligonucleotides into 
the MluI cut and processed pRZ6 5′ overhangs to create an internally labeled substrate (3′ 
overhang is shown for example). B. Three different substrates, 3-base partially 
complementary overhang substrate, 2-base recessed substrate with a 3′-phosphate and a  3′-
base partially complementary overhang substrate with a phosphotyrosyl group are shown. 
For convenience,  the labeled end is designated as the Head and the other end as Tail. 
pRZ56 
B. 
83 
 
                                                                        
 
 
                                                                                VIII. Results 
 
 
             Ionizing radiation and genotoxic agents often generate strand breaks with 
incompatible termini that must be processed by the repair pathways for chain extension and 
ligation. Some frequently occurring blocks are 3′-phosphate or 3′-phosphoglycolate ends,  and 
more rarely,  5′-hydroxyl ends. The 3′-phosphoglycolate ends are processed by TDP1, APE1, 
and Artemis (Menon & Povirk, 2016). The only known and confirmed enzyme that processes 
3′- phosphate and 5′-hydroxyl ends is polynucleotide kinase phosphatase (PNKP). Although 
its involvement in promoting cancer development is not elucidated, its role in normal 
neurological development has been extensively explored (Shimada, Dumitrache, Russell, & 
McKinnon, 2015). 
                         Like other DNA repair factors, PNKP loss leads to disruption of neurological 
development resulting in diseases such as oculomotor apraxia (Bras et al., 2015). PNKP plays 
a crucial role in the repair of strand breaks, both single and double, thus taking part in pivotal 
DNA repair pathways. This ubiquitous role of PNKP along with the lack of any other identified 
redundant factor to replace it, makes it a very attractive target for the treatment of cancer. 
Many small molecule inhibitors of PNKP were identified and tested to be used as a cancer 
therapy sensitizers (Freschauf et al., 2009). Therefore, the current study is done to explore 
the presence of alternative DNA 3′-phosphatases and 5′-kinases in the cell, which might have 
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the capacity to compensate for PNKP loss and promote resistance to PNKP inhibition. Two 
basic approaches to conduct the study are to  either deplete PNKP or inhibit PNKP activity. 
                     Nevertheless, experiments with PNKP knockdown cells and the PNKP inhibitor 
(A12B4C3) have shown little difference in processing of the 3′-phosphate ends produced by 
the treatment of HCT116 cells with 5 μM neocarzinostatin (NCS) which introduces 3′-
phosphate and 3′-phosphoglycolate DNA strand breaks  . Hence, to completely eliminate any 
residual activity of PNKP, we acquired PNKP knockout cells from Dr. Weinfeld’s lab. Whole 
cell extracts (WCE) were made from the HCT116 wild-type and the knockout cells, and  and 
32P-Internally labeled substrates with either a 3′-phosphate end or 5′-hydroxyl end were 
generated to test their processing in extracts, as described in the Methods section. In addition, 
HCT116 XRCC4 knockout and Bustel fibroblasts (XLF deficient) WCE were made to study 
their role in processing of the above substrates. 
            In parallel,  the PNKP knock-out status was confirmed using an antibody provided by 
Dr. Weinfeld. As shown in Fig. 6.1, there was no band corresponding to PNKP in western 
blots of  nuclear extracts of PNKP knockout cells when a monoclonal antibody detecting N-
terminal amino acids 1 - 140 was used as a probe. Furthermore, treatment with the drug NCS 
reduced the survival of PNKP knockout cells more than the wild-type cells. Also, the NHEJ 
repair foci measured as a function of the number of 53BP1 foci persisted in the knockout cells 
even after 8 hr, when all the foci in WT cells have disappeared. Considering the above results, 
we proceeded to perform in-vitro extract experiments to evaluate the removal of a phosphate 
from the 3′-end or  phosphorylate the 5′-end, allowing for the fill-in and end-joining of a DSB. 
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8.1 Processing of the DNA 3′-phosphate overhang and recessed ends: 
PNKP processes 3′-phosphate and 5′-hydroxyl ends at both single and double strand breaks 
of the DNA (Weinfeld, Mani, Abdou, Aceytuno, & Glover, 2011). In the current experiments, 
we wanted to explore the consequences of the loss of PNKP in processing different DSB 
substrates in the context of NHEJ. To assess the same, substrates with either a 3-base 
partially complementary 3′-overhangs or a complementary 3′-recessed ends with a 3′-
phosphate on one end were incubated separately, in either WT or PNKP knockout extracts 
for different times.  
     As shown in the figure 8.1, there will be removal of 3′-phosphate from the substrates by 
PNKP in the wild-type extracts, thereby leading to end-joining of some strands. We wanted to 
observe if the same would happen in the absence of PNKP. When the conversion of the 3′-
phosphate end to a 3′-hydroxyl end was measured as a function of time, when incubated in 
the extracts, wild-type HCT 116 cell extracts were able to remove about 50% of the 3′-
phosphate in the first 5 min and convert all the 3ʹ-phosphate into 3ʹ-hydroxyl within 45 min of 
incubation, while the PNKP knockout extracts showed a delayed (10X) and incomplete (76.7 
± 1.80%, n = 4) removal even at the end of the total period of incubation (6 hr), from the 
substrates with partially complementary 3ʹ overhangs (Fig. 8.2 A). Phosphate removal from 
the substrates with recessed 3′-ends on both sides, with 3ʹ-phosphate on one side, was 
incomplete ( 83.6 ±  4.06%, n = 3 ) even in wild-type cell extract, while most of the phosphate 
(70.9 ± 4.38%, n = 3), was retained in PNKP knockout extracts (Fig. 8.3 A).  
                  As the time progressed some of the ends were joined either Head-to-Tail or Head-
to-Head, with a fill-in (T) reaction (Fig. 8.1 A) occuring at the partial complementary –ACGp-
3′ overhangs. When this end-joining of the substrates was quantified, there was an increase 
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of joining observed for both the substrates with incubation time, in both WT and PNKP 
knockout extracts, albeit less in the knockouts. The Head-to-Tail end joining (42-bp) was 1.5 
± 0.17% (n = 4), and Head-to-Head end joining (24-bp) was 0.95 ± 0.10% (n = 4), for the 
overhang substrate in the WT vs 0.84% ± 0.05% and 0.56% ± 0.14%, for the knockouts. 
Owing to the complementarity recessed ends were joined effeciently, with a Head- to-Tail end 
joining (36-bp) of 3.7 ± 0.79% in WT vs. 2.75 ± 1.23% in knockout extracts (n =3) and the 
Head-to-Head end-joining(18-bp) was 2.5% ± 0.46% in WT vs. 0.98% in knockouts (n = 3) 
(Fig. 8.3 B and C).  The low Head-to-Head ligation compared to Head-to-tail can be attributed 
to the presence of 3′-phosphates on both the ends. 
      When the removal of phosphate was compared, there was a disparity observed in the 
processing of the overhang and recessed ends even in the WT extracts. This could be 
explained by the reduced accessibility of the 3′-phosphate at the recessed end, as the double 
strand needs to be unwound to place the phosphate group in the catalytic site (Coquelle et 
al., 2011). This unwinding being an energy-requiring process, could have limited the 
phosphatase activity at the recessed end. However, retention of a substantial amount of 3′-
phosphate at the recessed end indicates that  PNKP is the prime DNA 3′-phosphatase at the 
recessed 3′- DNA ends. Adding back PNKP (100 ng) to knockout extracts resulted in a wild-
type phenotype for phosphate removal from the overhang substrate. These observations 
suggest that in the absence of PNKP, still there is some processing of the 3′-DNA DSB ends. 
And the loss of activity in the knockout extracts can be attributed to loss of PNKP, since the 
activity could be restored on adding back recombinant PNKP (Appendix 1, Figure 1A). 
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Fig. 8.1: 3′-phosphatase and Nonhomologous end joining (NHEJ) of the 3′-phosphate 
overhang and recessed substrates:  Incubation of the 3′-phosphate substrates in the 
extracts results in the removal of 3′-phosphate producing a 3′-hydroxyl end which was 
compatible for end joining. For the partially complementary overhang substrates there will be 
a fill-in reaction (blue) before end joining, and on treatment with BstX1 and Taqα1, there will 
be the release of 42-nt and 24-nt, Head-to-Tail, and Head-to-Head end joining products, 
respectively(A) and a  36-nt and 18-nt, Head-to-Tail and Head-to-Head end joining products 
respectively,  for the recessed substrate (B). 
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Fig. 8.2: Repair of the double strand breaks of DNA with 3′- phosphate overhang by 
HCT116 WT and PNKP knockout extracts: Internally 32P -labeled DSB substrate with 
3′-partially complementary overhang were incubated in WT and PNKP knockout extracts 
for different times mentioned. The samples were later  proteolyzed and treated with TaqαI 
and BstxI, which were then run on a 20% polyacrylamide gel and exposed to a 
phosphoimager screen. The products of processing were visualized on a Typhoon 
scanner and quantified using ImageQuant 5.1. A. 3′- phosphate ends are converted into 
3′- hydroxyl ends in the extracts, some of which are either Head-to-Tail or Head-to-Head 
end joined, running parallel to the markers (M) of the predicted size and sequence. 
Because of the negative charge, the unjoined fragment with the 3′-phosphate end runs 
faster than the one with 3′-hydroxyl end. Plots display the percentage of phosphate 
removal (B), and percentage of end-joining of the Head-to-Tail – 42-nt (C) and  Head-to-
Head - 24 end joining (D) in WT and PNKP knockout extracts ( * -- p < 0.05, ** -- p < 
0.005; Student t-test) ( n = 4) 
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Fig. 8.3: Processing of the substrate with a recessed 3′-phosphate end at the DSB 
by HCT116 WT and PNKP knockout extracts: 32P-labeled 3′-phosphate DSB recessed 
end substrates are incubated as indicated and processed similarly to overhang substrates 
and run on a gel (A). Plots show the increase in percentage of phosphate removal (B) 
and end-joining of the Head-to-Tail – 36-nt (C) and Head-to-Head – 18-nt (D),  in WT and 
PNKP knockout extracts, as a measure with time. (**  -- p < 0.005; Student t-test) (n = 3) 
 
 
   
 
B. A. 
D. 
90 
 
8.2 Processing of the 3′-tyrosyl substrates in PNKP knockout extracts: 
PNKP is also shown to function as a processor of the intermediate 3′-phosphate DNA 
ends formed during processing of other complex lesions. For example, chemotherapeutic 
drugs such as camptothecin inhibit the re-ligation function of topoisomerase I enzyme, by 
inducing the formation of DNA-TOP1 protein covalent complexes at the 3′ end of the DNA 
(Plo et al., 2003). These complexes are further processed by peptidases to leave a shorter 
peptide linked via a tyrosine residue to the DNA 3′-end forming a covalent 
phosphoenzyme intermediate (Gottlin, Rudolph, Zhao, Matthews, & Dixon, 1998). This 
DNA-protein complex is resolved by TDP1 enzyme leaving a 3′-phosphate (Interthal et 
al., 2005). The removal of this 3′-phosphate is dependent on the enzyme PNKP (T. Zhou 
et al., 2009). Hence, to evaluate the processing the DNA-TOP1 complexes in the absence 
of PNKP, a DNA 3′-tyrosyl substrate which mimicks the ligand acted upon by TDP1 was 
constructed.  
         Similar to the above experiments, the 3′-phosphotyrosyl substrate was incubated 
with WT and PNKP knockout extracts. While in the WT extracts, 3′-phosphotyrosyl ends 
were directly converted into 3′-hydroxyl with no detectable intermediates (Fig. 8.4 A lanes 
2-7), accumulation of 3′-phosphate was observed in the knockout extracts (Fig. 8.4 A 
lanes 7-12). This observation reiterates the requirement of PNKP for the removal of 3′-
phosphate from the TDP1-processed ends and that loss of PNKP in the knockouts has 
prevented its conversion to 3′-hydroxyl and not compensated by any other 3′ phosphatase 
for its loss, at least in a part of them. The disappearance of the 3′-phosphotyrosyl is 
similarly incomplete in both WT and the knockouts likely due to the extracts containing 
insufficient TDP1 to process all the substrate (Fig. 8.4).  
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Fig. 8.4: 3′-phosphotyrosyl end processing at the DSB: DNA DSB substrate 
mimicking that of the substrate acted upon the TDP1 enzyme was designed by ligating a 
radio-labeled oligo with 3′-phosphotyrosyl end at the overhang. This substrate was 
incubated in the extracts for different times, processed as in Fig. 8.2, run on a gel and 
imaged (A), and the percentage of products formed after processing were plotted 
separately for HCT116 WT (upper panel) and PNKP knockout (lower) extracts (B) (n = 
2).  Accumulation of 3′-phosphate band was visualized in PNKP knockout extracts only. 
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8.3 Role of other known 3′-phosphatases in the processing the DNA double-strand 
breaks: 
PNKP is the sole 3ʹ-phosphatase known to be involved in the repair of DSB’s by 
nonhomologous end joining. However, our studies using PNKP knockout extracts have 
demonstrated a residual 3′-phosphatase activity at the DSB’s. There is an other enzyme, 
APE1, with a weak 3ʹ-phosphatase activity at the SSB’s in the context of BER (Chen, 
Herman, & Demple, 1991). Its role in the repair of DSB end-joining is yet to be elucidated. 
Aprataxin is another enzyme with limited evidence of 3′-phosphatase activity at the SSB’s, 
recessed DSB’s, nicked or gapped DNA (Takahashi et al., 2007). Since these two 
enzymes act preferably at the SSB’s, it was hypothesized that end-joining of the 
complementary strand at the DSB leaves an SSB with the 3′-phosphate, mimiking a nick, 
which can be further processed by either APE-1 or Aprataxin. 
             To determine whether the ligation of opposite strand is promoting the repair of 
the 3′-phosphate end, ligation of the complementary strand was prevented. Since the 
ligation of 3′-ACG overhangs requires a fill-in by dTTP in both the strands (as shown in 
Fig. 8.1 A), substitution of ddTTP in place of dTTP was attempted to allow the fill-in 
reaction but prohibit the ligation. If the ligation of complementary strand instigates the 
repair of 3′-phosphate end at the SSB created, blocking this ligation should limit the fill-in 
reaction. However, when the reactions were carried out with ddTTP in the reaction, similar 
processing (3′-phosphate to 3′-hydroxyl) resulting in equal fill-in at the 3′- 14-nt unjoined 
end WT 2.73% vs PNKP -/- 2.9%, to produce 15-nt (one base extended), was observed 
after 6 hr of incubation (Fig. 8.4).  This observation rules out the role of complementary 
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strand ligation in promoting the processing of the 3′-phosphate end at the DSB in PNKP 
knockout extracts and thus rules out the role of APE1 and Aprataxin in DSB repair, atleast 
at the 3′-phosphate end. 
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 Fig. 8.5: Role of other 3′-phosphatases in the processing DNA double-strand 
breaks: HCT116 WT and PNKP knockout extracts were incubated with the 3′-overhang 
substrate in the presence of  ddTTP (lane 2 and 4), to block the end-joining of both the 
strands after fill-in to eliminate the role of complementary strand ligation in processing the 
3′-phosphate end at the DSB’s. A fill-in reaction produces a band corresponding to one 
nucleotide higher (15) than the unjoined fragment as a result of blocking the end-joining. 
As expected, we could block the end joining in lane 2 and 4, however there was a 
prominent a nucleotide fill-in at the unjoined ends, suggesting the removal of 3′-phosphate 
even in PNKP knockout extracts (lane 2). 
1  2   3  4   5 
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8.4 Identifying the presence of a non-conventional DNA 5′-kinase in the mammalian 
cells:  
            PNKP is the only known DNA 5′-kinase in the mammalian cell. Evidence of DNA 
3′-phosphatase activity in the PNKP knockout extracts brings into question the knockout 
status of the cells. To verify if this activity is due to residual activity or perhaps another 
isoform of PNKP, we resorted to check the kinase activity on a 5′-OH substrate in these 
extracts.  
            Initially, an indirect phosphorylation assay was done with internally labeled 3′-
phosphate overhang substrate treated with CIP to create a recessed 5′-hydroxyl ended 
substrate with a 3′-hydroxyl ends, in PNKP knockout extracts. For the  DNA DSB end 
joining, the 5′-hydroxyl must be converted to a 5′-phosphate, and the only known 
converter is PNKP enzyme. However, some end-joining was observed for the substrates 
with the 5′-hydroxyl end suggesting that there was phosphorylation of the 5′-hydroxyl end 
in the absence of PNKP (Fig. 8.6 A lane 5). There was enjoining seen with the 3′-hydroxyl 
and 5′-phosphate ended (normal) DSB substrates (Fig. 8.6 A lane 7), as well as in 3′-
phosphate and 5′-phosphate ended DSB substrates (Fig. 8.6 A lane 3), which was similar 
to the observation made in Fig. 8.5. However addition of ddTTP abolished the ligation for 
all the substrates, indirectly suffesting a fill-in occuring at all the substrates (lane 2,4 and 
6). 
                         One possible reason for this observation can be the 5′-hydroxyl strand 
displacement occurring after the 3′-end extension by polymerase δ/ε, and removal of the 
5′-hydroxyl flap by FEN-1, simulating the long patch BER (Dobson & Allinson, 2006). For 
the extension of the strand to occurs, there must be a fill-in by dTTP follwed by dCTP and 
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dGTP in line. Hence to explore the possibility of strand displacement, experiments were 
done with ddGTP or ddCTP substitution in the reactions. If the strand extension occurs 
by incorporating one of these dideoxynucleotides at the 3′ end, a block in the ligation 
should be seen along with increased unjoined fragment length. However, neither of these 
substitutions resulted in either the ligation block or the extension of the unjoined product 
(Fig. 8.6 B). Hence, the end-joining must have occurred due to direct conversion of the 
5′-hydroxyl end to a 5′-phosphate end by a DNA 3′-phosphatase enzyme, rather than a 
strand displacement followed by endonuclease (FEN-1) mediated trimming of the 
displaced strand. These results led us to a second possibility, presence of a non-
conventional DNA 5′-kinase. 
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Fig. 8.6: A. Compatibility of the 5′- hydroxyl ends for the end joining: Kinase activity 
was screened indirectly by assesing the end joining of 3′-hydroxyl and recessed 5′-
hydroxyl ends (lane 5) as compared to the end-joining of 3′-hydroxyl and recessed 5′-
phosphate ends (lane 7), and 3′-phosphate and recessed 5′-phosphate ends (lane 3), all 
labeled on the 3′ strands, as a control,  in HCT116 PNKP knockout extracts 
B. Strand displacement in substrates with 5′-OH end for bypassing the blocked 
5′end for strand ligation: Substrates with a 3′-hydroxyl end and either a opposite 5′-
hydroxyl (lane 1,3,6 and 8) or a 5′-phosphate end (lane 2,4,5 and 7), were incubated 
separately in WT or knockout extracts in the presence of ddGTP (lane 1,2 5 and 6) or 
ddCTP (lane 3,4,7 and 8) instead of the normal counterparts, dGTP and dCTP, which 
would  fill-in succession to dTTP at the 3′-end to initiate strand displacement of  the 5′-
hydroxyl end. W = HCT116 Wild-type extract, P = HCT116 PNKP knockout extract 
A. 
B. 
1 2  3 4 5  6 7 1 2 3 4      5 6 7 8            9 
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8.5 Evaluation of DNA 5′-kinase activity in the extracts:  
PNKP enzyme preferentially dephosphorylates 5′-hydroxyl termini within nicked, gapped 
or DSBs with single-stranded 3′ overhanging ends, compared to single-stranded 5′- 
termini or blunt double-stranded (Karimi-Busheri & Weinfeld, 1997). Therefore, in this 
assay, instead of a 3′-end-labeled substrate, a 5′-hydroxyl substrate which was internally 
labeled on the same strand was tested for the kinase activity in both HCT116 WT and 
PNKP knockout extracts. As observed in Fig. 8.7 B, incubation of the substrates in the 
extracts for 6 hours converts the 5′-hydroxyl to a 5′-phosphate, in both extracts albeit to a 
lesser extent in the knockout extracts. While 34 ± 6.7% of the 5′-hydroxyl ends were 
converted in WT extracts (lane 4), only 6.9 ± 1.5% were converted in PNKP knockout 
extracts (lane 5). Pure PNKP (30 ng) (lane 2) and T4PNK (5 U) (lane 3), were used as 
positive controls. The conversion of 5′-hydroxyl end observed in knockout extracts might 
be an indication of the presence of residual PNKP or the another yet un-known DNA 5′-
kinase, which needs to be explored further. 
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Fig. 8.7: Plasmid DNA DSB’s with 5′-hydroxyl end processing: A. Illustration of 5′- 
hydroxyl ends of the DNA DSB substrate constructed by radiolabeling the XmaI cut 5′ 
ends of pUC19, on either side and ligating an oligomeric duplex with a recessed 5′-
hydroxyl ends. B. These DSB substrates were treated with pure PNKP (lane 2) and 
T4PNK (lane 3) (1hr), WT (lane 4), and PNKP knockout extracts (lane 5) (6 hr) to observe 
for the conversion of a 5′-hydroxyl to 5′-phosphate. These processed substrates were cut 
with SmaI to be run on a gel after proteolysis. C. The percentage of phosphorylation 
observed at the 5′-hydroxyl ends in HCT116 WT (lane 4) and PNKP knockout extracts 
(lane 5) were plotted. (* - p < 0.05; Student t-test) (n = 3) 
 
* 
1 2 3 4  5    
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8.6 Evaluating the 3′-phosphatase function observed in the extracts as a function 
of NHEJ: 
                        PNKP enzyme has the propensity to act on both SSB’s and DSB’s in 
multiple repair pathways. Studies have shown that ATM and DNA-PKcs mediate  
phosphorylation of PNKP at serines 114 and 12 in a damage-dependent manner (Zolner 
et al., 2011a). This phosphorylation, although it does not influence the kinetics of PNKP 
accumulation, was shown to increase the turnover of PNKP at the DNA damage sites 
(Zolner et al., 2011b). It was also shown that the substitution of T4PNK in PNKP-
immunodepleted extracts could not restore the end-joining of 5′-hydroxyl substrates 
implying the inaccessibility of the NHEJ protein-bound DNA to a non-specific kinase 
(Chappell et al., 2002). Moreover, autophosphorylation of  DNA-PK complex (Ku+DNA-
PKcs), is required for the internal translocation of the complex at the DSB to provide 
access to other processing factors to repair/restore the ends for ligation.  
                This access to to the DSB ends can be blocked by a DNA-PK inhibitor, which 
will block the autophosphorylation and thus opening up of the DNA-PK complex. In the 
previous experiments done in the lab with TDP1 protein to prove its role as a NHEJ factor, 
a DNA-PK inhibitor, NU7441, was used to block the access of the 3′-phosphoglycolate 
overhanging ends at the DSB’s to TDP1 enzyme which processes its removal (T. Zhou 
et al., 2009). To assess whether the observed 3′-phosphatase activity at the DSBs in the 
PNKP knockout extracts is a function of NHEJ, NU7441 was used in the reactions.   
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                Both the HCT116 WT and PNKP knockout extracts were pre-incubated with 
NU7441 for 10 minutes before the addition of the 3′-phosphate substrate. Significant 
inhibition of the phosphatase activity (Fig. 8.8), WT by 49 ± 15.58% (lane 4) and PNKP-
/- by 85 ± 4.8% (lane 8) at 1 μM concentration and by 68 ± 8.1% (WT) (lane 5) and 89 ± 
3.78% (PNKP-/-) (lane 9) at 10 μM concentration was seen for the overhang substrate.  
There was a likewise significant reduction in the removal of the recessed 3′-phosphate 
with 1 μM NU7441 inhibiting the phosphate removal by 62 ± 1.8% in WT (lane 4) and by 
81 ± 0.5% in PNKP-/- extracts (lane 8), while addition of 10 μM NU7441 reduced the 
removal by 78 ± 2.1% in WT (lane 5) and by 87 ± 0.78% (lane 9) in PNKP-/- extracts.  
                By comparison, there was a significant decrease in the recessed end 
processing relative to overhang processing in the presence of NU7441 in WT extracts as 
seen in the plots of overhang ends and recessed ends (Fig. 8.8), signifying the major role 
played by PNKP in processing the recessed DNA 3′-phosphate ends, which was shown   
by a significant reduction in processing of these ends in PNKP knockout extracts (Fig. 
8.3). Furthermore, a significant decrease in processing of the ends, even in knockout 
extracts, suggests that the repair factor is depending on DNA-PK function for processing 
the ends and hence is a part of NHEJ. 
8.7 Accessibility of the 3′-phosphate ends to tissue non-specific alkaline 
phosphatase enzyme (CIP):  
           To reaffirm that the unknown DNA  3′-phosphatase in the cell is a part of NHEJ, 
after 10 min of preincubation of extracts with NU7441, followed by recessed 3′-phosphate 
substrate incubation for 10 min, 5 units of CIP (a DNA 3′ and 5′-phosphatase) was added 
to some reactions. CIP was added to the extracts after preincubation with the inhibitor in 
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order to prevent it robust phosphatase activity on the ends even before the formation of 
DNA-PK complex.  
              As evident from Fig. 8.9, in the presence of PNKP in the wild-type extracts, 85% 
of the 3′-phosphate ends were processed (lane 1), with a reduction in the removal of 3′-
phosphate to 39.6% in PNKP knockout extract (lane 2). Addition of CIP did not enhance 
the phosphate removal in WT extracts (lane 3), while it enhanced the removal in the PNKP  
knockout extracts to 74% (lane 4). 10 μM NU7441, on the other hand could suppress the 
phosphatase activity in both WT and PNKP knockout extracts to 31% and 7.4%, 
respectively (lane 5 and 6).  
                 However, 10 μM NU7441 does not block the 3′-phosphatase activity of CIP, 
79% (vs. 85% no drug) in WT (lane 7) and 70% (vs. 74%) in PNKP knockout extract (lane 
8), suggesting that DNA-PK inhibition is capable of blocking only the activity only if it is a 
part of NHEJ, but not the non-specific phosphatase enzyme’s activity. While, PNKP and 
the other 3′-phosphatase enzyme in the PNKP knockout extracts depend on the 
phosphorylation by DNA-PK for the activity at the DSB, CIP can funtion independantly of 
the same, suggesting that the alternative enzyme in the knockout extracts is not a non-
specific but a NHEJ factor.   
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Fig. 8.8: 3′-phosphatase activity as a function of NHEJ: DNA-PKcs inhibitor, NU7441 
was used to block the access of the DSB’s by the enzymes that processes the 3′-
phosphate ends as a part of NHEJ. NU7441 at concentrations 1 μM and 10 μM (lane 4,8, 
and lane 5,9, respectively) was added to both HCT116 WT and PNKP knockout extracts 
to test for the inhibition of processing of overhangs (upper panel) and recessed ends 
(lower panel), with 3′-phosphates at the DSB’s. The observed level of phosphatase 
activity in the extracts was plotted as a percentage of phosphate removal at the mentioned 
concentrations of the NU7441 along with controls. Inhibition of activity was evident at both 
drug concentrations (lane 4,8, and lane 5,9) Statistical significance: * - WT VS. NU7441 
treated WT, $ - PNKP-/-  VS. NU7441 treated PNKP -/- (* , $ - p<0.05; ** ,$$ - p< 0.005; 
*** ,$$$ - p<0.0005 - One way ANOVA- Dunnett test ) (n = 3) ( C = No drug/DMSO, D = 
DMSO). 
 
1    2    3    4    5    6   7    8   9 
1    2    3    4    5    6   7    8   9 
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Fig. 8.9: Alkaline phosphatase activity on DNA 3′-phosphate recessed end 
substrates: DNA 3′-phosphate recessed end substrates were incubated with HCT 116 
WT extracts (bar 1) or PNKP knockout extracts (bar 2), some of which were pretreated 
with 10 μM NU7441 10 min (lane 5,6,7 and 8). CIP was added to some extracts after 
incubation of the substrate in the NU7441 non-treated (bars 3 and 4) and the treated (bars 
7 and 8) extracts after 10 min of the incubation of the substrate. The observed phosphate 
removal after 6 hr of incubation after addition of CIP,  was plotted as a percentage for 
each reaction. The plot reveals the inability of the DNA-PK inhibitor to block the CIP (non-
specific) activity while it is blocking the phosphatase activity in the PNKP knockouts. (W = Wild-
Type; P = PNKP-/-; C = CIP; N = NU7441) (n = 1) 
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8.8 Sub-cellular localization of 3′phosphatase activity: 
                 DNA phosphate ends can also be dephosphorylated by the tissue non-specific 
alkaline phosphatase enzyme which is membrane-bound mostly in the extracellular and 
cytoplasmic compartments with minimal expression in the nucleus (Hsiang, Hertzberg, 
Hecht, & Liu, 1985). However, this activity has no specificity for either 3′ or 5′ ends. PNKP 
is a nuclear enzyme and is found in small quantities in mitochondria. Depletion of nuclear 
PNKP with shRNA was shown to deplete mtPNKP (Tahbaz, Subedi, & Weinfeld, 2012). 
Experiments performed in whole cell extracts revealed a 3′-phosphatase activity even in 
the absence of PNKP.  
            To compartmentalize the observed 3′-phosphatase activity in the knockout 
extracts, nuclear/cytosolic fractionation was made using BioVision kit. Overhang 3′-
phosphate substrates were incubated for different times as shown in Fig. 8.10 A. Similar 
to the whole cell extracts, there was 3′-phosphatase activity (80 ± 0.12%) in the PNKP 
knockout nuclear extracts after 120 min incubation (Fig. 8.10 A lane 7). This suggests 
that the suspected DNA 3′- phosphatase enzyme acting at the DSB is present in the 
nucleus. Also, there was digestion of the DNA seen on incubation of the overhang 
substrates for 120 min in both the extracts, suggesting possible exonucleolytic digestion 
of the converted 3′ hydroxyl ends. The digestion of the processed ends is probably due 
to a lack of protection of these ends which would be present in whole cell extracts.  
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Fig. 8.10: Detection of 3′ phosphatase activity in the nuclear extracts: A. Overhang 
3′-phosphate substrates were incubated in the HCT116 WT or PNKP-/- extracts for 5, 30 
and 120 min, processed and run on the gel. B. Observed removal of phosphate in both 
the extracts was plotted as a percentage of time. Phosphatase activity was evident in the 
PNKP knockout nuclear extracts (lane 3, 5 and 7). (n = 2) 
 
 
 
A. 
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8.9 Assessing the role of XRCC4 in DNA kinase and phosphatase activities: 
                  DNA-PK, a core NHEJ factor was shown to influence the DNA 3′-phosphatase 
activity in the above experiments. Numerous studies on the role of XRCC4, another core 
NHEJ factor, interacting with and influencing the function of PNKP, have revealed 
complex interactions (Aceytuno et al., 2017b) (Chappell et al., 2002) (Mani et al., 2010a). 
As with the other accessory repair proteins, PNKP also interacts with the scaffold formed 
by XLF and XRCC4/LigaseIV complex. PNKP interaction with XRCC4 is by dual modes, 
with phosphorylated (pXRCC4) and non-phosphorylated form (XRCC4) (Fig. 6.1 B). 
Interacting with XRCC4 or pXRCC4/LigaseIV is shown to increase PNKP turnover at the 
5′-hydroxyl ends after phosphorylation, and the lack of XRCC4 has reduce the kinase 
activity (Mani et al., 2010b). Phosphatase activity of PNKP was shown to be predominant 
over kinase activity (Dobson & Allinson, 2006). Nevertheless, not much work has been 
done regarding the effect of XRCC4 on the DNA 3′-phosphatase activity of PNKP.  
                 By adding  HCT116 XRCC4 knockout extracts to the DNA 3′-hydroxyl and 5′-
phosphate substrates, we attempted to define XRCC4’s role in PNKP activity. The 
observed activity in these extracts was compared to the activity in HCT116 WT extracts 
(lane 1), HCT116 PNKP knockout extracts (lane 2), and to the activity restored after the 
addition of pure protein 0.6 µg of XRCC4 (lane 4) or pure 30 ng of PNKP to the XRCC4 
knockout extracts. As observed in the Fig. 8.11, the absence of XRCC4 in the extracts 
has reduced the phosphatase by 47 ± 6.1% and kinase activity by 40 ± 1.4% as compared 
to the wild-type extracts (lane 3). There was no end-joining observed in either the WT or 
PNKP knockout extracts since the incubation period was only one hour for 3′-phosphate 
substrates and due to incompatible ends in 5′-hydroxyl substrates, incubated for 5 hours.                          
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Adding back 0.6 μg  XRCC4/LigaseIV protein not only enhanced the 5′-kinase (58 ± 10%) 
and 3′-phosphatase activities (92 ± 7.4%), but also strongly promoted end-joining for both 
the substrates (lane 4). This suggests that even at the physiological concentrations of 
PNKP present in the extracts, it requires XRCC4 for the enhancement of the catalytic 
activity.  Adding 30 ng of pure PNKP, there was an obvious (37 ± 8.3%) increase in the 
3′-phosphatase activity (similar to WT) and around 3.8 ± 0.25% increase in the 5′-kinase 
activity (still somewhat less than WT) in XRCC4-/- extracts (lane 5).  This further proves 
that while the added PNKP can act on the available 3′-phosphate ends, XRCC4 is 
required to reduce its affinity at the phosphorylated ends, and therefore absence of 
XRCC4 in the knockouts attenuates the turnover of the added PNKP, limiting the kinase 
activity. End joining of the non-complementary ends of hydroxyl substrates proves the 
ability of XRCC4/Ligase IV to promote ligation such ends. And also, since the experiment 
with both the substrates is performed in parallel using the same extracts, the difference 
in potency of the DNA 3′-phosphatase activity vs. 5′-kinase activity of PNKP is clearly 
seen for all the extracts and protein additions. As reported, the phosphatase activity (1 hr 
incubation) is predominant over kinase activity (5 hr incubation)..  
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Fig. 8.11: XRCC4/LigaseIV enhances  PNKP activity: HCT116 XRCC4 knockout cell 
extracts were used to assess the DNA 3′-phosphatase (1hr incubation), and 5′-kinase 
activities (5 hr incubation), using respective substrates. Recombinant proteins, 0.6 μg of 
XRCC4/LigaseIV and 100 ng of PNKP were added to these extracts, separately. A. Gel 
images of the products resulting from processing of 3′-phosphate (right panel) and 5′-
hydroxyl (left panel) substrates  B. Percentage of conversions of each substrate ends is 
plotted. While the lack of XRCC4 reduced the activities (lane 3), adding back XRCC4 to 
the knockout increased the activities, and promoted end joining (lane 4), while the added 
PNKP stimulated phosphatase activity only (lane 5). 1. Wild-type, 2. PNKP knockout, 3. 
XRCC4 knockout, 4. XRCC4 knockout+recombinant XRCC4, 5. XRCC4 knockout + pure 
PNKP. (n = 3) 
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8.10 Role of XLF in processing the 3′-phosphate or  5′-hydroxyl ended DNA DSB’s: 
              Previous studies evaluating the role of XRCC4 in PNKP function have shown 
either a non-phosphorylated XRCC4 or an XRCC4/LigIV complex, independent of Thr-
233 phosphorylation status increases the turnover of PNKP at the 5′-phosphorylated ends 
of DNA DSB’s (Mani et al., 2010). XRCC4 interacts with XLF creating a helical filament 
of alternating XRCC4 and XLF dimers, thus stabilizing DNA end synapsis (Wu et al., 
2011). XLF is shown to promote the re-adenylation of DNA Ligase IV, thus reactivating 
its active site, independent of its interaction with XRCC4 (Roy et al., 2015).  
          Based on this evidence, an attempt was made to study XLF’s role in phosphatase 
and kinase activities in  Bustel fibroblast extracts (deficient in XLF). 3′-phosphate DNA 
DSB substrates and 5′-hydroxyl DNA DSB substrates were employed to evaluate the 
phosphatase and kinase activities respectively. Upon incubation for 6 hr in Bus extracts 
with and without complementation of XLF, an increase in the kinase activity by 30.7 ± 
3.2% was observed on XLF substitution ( Fig. 8.12 lane 9) with no discernable change in 
phosphatase activity on both overhang (lane 2 and 3) and recessed 3′-phosphate 
substrates (lane 5 and 6), suggesting a possible influence of XLF in processing the 5′-
hydroxyl at DSB’s by PNKP, by increasing its turnover similar to XRCC4. End joining of 
phosphate substrates has occurred in the presence of XLF (lane 3 and 6), which could 
not occur in its absence (lane 2 and 5), reinstating the requirement of XLF for the ligation 
of a DSB, especially in extracts. However, owing to the non-complementarity of the ends, 
there was no end joining of 5′-hydroxyl substrates. 
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Fig. 8.12: Effect of XLF on the phosphatase and kinase activity: Substrates with 3′-
phosphate (overhang (lane 1,2 and 3) or recessed (lane 4,5 and 6)) or 5′-hydroxyl ends 
(lane 7,8 and 9, at the DSB’s were incubated in Bus extract with (lane 3,6,9)/without 
XLF(lane 2,5 and 8) for 6 hr,  and the phosphatase and kinase activities were assessed 
by measuring the conversion of the 3′-phosphate ends to 3′-hydroxyl ends and 5′-hydroxyl 
ends to 5′-phosphate ends. B. The observed   kinase activity in the presence and absence 
of XLF was plotted as percentage. As observed on the gel there was no difference in the 
presence and of XLF in phosphatatase activity (lane 2 vs. lane 3 and lane 5 vs. lane 6). 
However, kinase activity was stimulated by PNKP (lane 8 vs. lane9). There was promotion 
of end joining for both the 3′-phosphate substrates (lanes 3 and 6). (n = 3)  
B. 
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        Results from all the above experiments led to two speculations. One possibility is 
that there could be either residual PNKP due to insufficient knockout or the presence of 
an isoform of PNKP. Literature reveals that there is another isoform of PNKP which is 40 
amino acids shorter at the aminoterminal FHA region where the first 1-50 aminoacids 
MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQ are 
replaced by   MQILTPPLQSS (GCID:GC19M049861). However, CRISPR mediated 
targetting of Exon3 would knock out both the isoforms. The other possibility is the 
presence of alternative DNA 3′-phosphatases and 5′-kinases.  
8.11 Detection of  PNKP by Western Blot using alternative antibodies:  
The only confirmation to this point regarding the knockout status of the HCT116 cells is 
the western blot analysis done by using a mouse monoclonal antibody targeting an 
epitope of aa 1-140 of PNKP which detects the FHA domain of PNKP. PNKP interacts 
with XRCC4 via the FHA domain (pXRCC4) and the catalytic domain (XRCC4) at the 
DSBs (Mani et al., 2010b). Lack of detection of the FHA domain leaves a possible 
presence of catalytic domain (phosphatase and kinase) which might be responsible for 
the observed activity in the extracts.  
      Western blot experiments were repeated using  Rabbit anti-PNKP polyclonal antibody 
(full-length epitope) and a mouse anti-PNKP monoclonal antibody which detects C-
terminal aa 379-411, for verifying the presence or absence of the catalytic domain of 
PNKP (Fig. 8.13 A  and B). Surprisingly, there was a band detection with both the 
antibodies (Fig. 8.13 lane 5 (left and right panels)).  For PNKP knockout in these cells, 
CRISPR was targeted Exon 3 (Appendix II), resulting in deletion and rearrangement in 
Allele 1 and an in-frame insertion and two site mutation in Allele 2. While the first allele 
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targetting should eliminate the expression of the protein, the insertion in the second allele 
targetting appeared to allow for expression of a full-length protein. However, the observed 
band (lane 5, right panel) appeared slightly lower in the gel than the full-length protein, 
which is not consistent with an in-frame insertion. This observation suggests a possible 
presence of a truncated PNKP, although its contribution to the activity seen in the 
knockout extracts requires further elucidation. 
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Fig. 8.13: PNKP detection in the knockout extracts by Western blot: HCT116 WT 
and PNKP knockout cytoplasmic and nuclear extracts extracts (50 µg) were resolved on 
10% SDS-PAGE. After transfer to 0.45 μm nitrocellulose the blotted bands were 
immunodetected with either a rabbit anti-PNKP polyclonal antibody (whole protein 
epitope) (A) and  mouse anti-PNKP monoclonal antibody (Mab)  (aa 379-411 epitope) (B) 
and subsequently visualized with peroxidase labeled rabbit anti-rabbit IgG (A) or anti-
mouse IgG (B) antibodies. Band detected in the WT nuclear extracts (lane 4) is migrating 
with the recombinant protein (lane 1). There is a  band detected in lane 5 (PNKP knockout 
nuclear) of both the blots with the band in the right panel running faster than the WT. 
GAPDH was used as a loading control. For both the blots, Lane1: Recombinant hPNKP, 
Lane 2: HCT116 WT cytoplasmic extract, Lane 3: HCT116 PNKP knockout cytoplasmic 
extract, Lane 4: HCT116 WT nuclear extract, Lane 5: HCT116 PNKP knockout nuclear 
extract, kD: kilo Dalton – molecular weight of the protein.  
  PNKP  
 GAPDH 
Rabbit anti-PNKP polyclonal  
antibody (full length) 
Mouse anti-PNKP monoclonal 
antibody (aa 379-411)  
1     2    3    4           5  1     2    3    4            5  
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8.12 Dilutional analysis of the detected PNKP:  
         The appearance of this band was not be predicted by DNA sequencing of the 
knockout but could not be attributed to the PNKP isoform which is approximately 4 kD 
less than the conventional PNKP. We quantified the band detected in knockout extracts 
as a fraction of that detected in wild-type extracts by the mouse Mab.  
           Starting with 2 mg/ml, priteins contained in increasing dilutions of HCT116 wild-
type nuclear extracts were resolved on AnyKD gel along with the 2 mg/ml of PNKP 
knockout nuclear extract. The sensitivity of detection of PNKP was increased by using 
SuperSignal™ Western Blot Enhancer kit. After transfer to 0.45 μm nitrocellulose 
membrane, the blot was incubated with antigen pretreatment solution for 10 min before 
blocking, followed by incubation with the mouse Mab (aa 379-411) in the primary antibody 
diluent provided in the kit. These blot treatments resulted in a clear enhancement of the 
bands with less background. The intensity of the bands detected on the blots was 
measured using ImageJ software. As seen in the Fig. 8.14, the band detected in PNKP 
knockout extract appeared to be running as a doublet (lane 8). When quantified and 
interpolated to the dilutions of the HCT116 WT nuclear extracts on a log scale; it was 
found to be approximately 1/13th  of the level found in WT nuclear extracts. 
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Fig. 8.14: Dilutional analysis of PNKP in the knockout nuclear extracts: Increasing 
dilutions of the HCT116 WT nuclear extract (Lanes 2 to 7) along with the PNKP knockout 
extract (lane 8) were resolved on AnyKD gel, transferred on to to 0.45 μm nitrocellulose 
membrane was treated with SuperSignalTM antigen pretreatment solution for 10 min 
before being blocked. The mouse anti-PNKP Mab (aa 379-411), was diluted in the 
SuperSignalTM primary antibody diluent for overnight incubation of the blot which was 
subsequently visualized with peroxidase labeled anti-mouse IgG. Image J software was 
used to quantify the band intensities which were plotted to derive the intensity of the band 
detected in the PNKP knoctouts as a fraction of WT intensities. GAPDH was used as a 
loading control. The band detected in lane 8 (PNKP knockout) appears to be running like 
a doublet and its intensity was approximately 1/13th of the WT undiluted extract. Lane 1: 
Recombinant PNKP, Lane 2-7: Increasing dilutions of HCT116 WT nuclear extract, Lane 
8: HCT116 PNKP knockout nuclear extract.  
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8.13 Western blots on HeLa extracts:  
        Due to the possibility of the band detected by PNKP antibody in the HCT116 PNKP 
knockouts to be  functional PNKP, we have also obtained HeLa PNKP Knockout cells 
from Dr. Weinfeld along with CRISPR controls to repeat the phosphatase and kinase 
assays. The gene sequencing data (Appendix II) and the western blot provided by his 
laboratory suggested a clean knockout of all the three allelles of PNKP. Western blot 
analysis of the cytoplasmic and nuclear extracts of the cells  was done using the rabbit 
anti-PNKP polyclonal antibody (full-length epitope) and a mouse anti-PNKP Mab (379-
411).  
       As shown in the Fig. 8.15, after probing with peroxidase tagged specific secondary 
antibodies, there was a faint band (lane 5) detected with the polyclonal antibody after 5 
min exposure, without any band detection mouse monoclonal antibody (lane 5) even after 
30 min exposure to X-ray screen. This lack of band detection suggested a clean knockout 
of PNKP in the HeLa extracts. These extracts were used to corroborate the findings 
obtained for processing the 3′-phosphate and 5′-hydroxyl ends in HCT116 PNKP 
knockout extracts. 
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Fig. 8.15: PNKP knockout status verification on Western blot: HeLa WT and PNKP 
knockout extracts were resolved on 10% SDS-PAGE  and transferred on to to 0.45 μm 
nitrocellulose membrane, which was treated with mouse anti-PNKP Mab targeting aa 379-
411 (top panel), rabbit anti-PNKP antibody (full-length) (middle panel) and detected with 
peroxidase labeled specific secondary IgG.  While the lane 5 in the top panel was clean 
even after 30 min exposure, a faint band was detected anti-rabbit secondary (lane 5) after 
5 min exposure to X-ray. GAPDH control was detected with Alexa Flour 680 labeled anti-
mouse IgG (bottom panel). 
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8.14 Experiments in HeLa Extracts: 
              To substantiate the findings made in the HCT116 knockout extracts and to rule 
out that the band detected in the HCT116 PNKP knockout extracts (Fig. 8.13 lane 5 (right 
panel) and Fig. 8.14 lane 7) is contributing to the activity seen in those extracts, HeLa 
PNKP knockout extracts which were confirmed to lack any PNKP by the same antibodies 
that detected its presence in HCT116 knockouts, were used to study the DNA 3′-
phosphatase and 5′-kinase activities. As with the above experiments in HCT116 extracts, 
the 3′ –phosphate and 5′-hydroxyl substrates were incubated in the wild-type and PNKP 
knockout whole cell extracts for various times.  
                These experiments have revealed similar processing of the 3′-phosphate 
recessed end, WT- 88.27 ± 1.68% vs. PNKP-/- - 33.0 ± 1.85%, with the retention of some 
3′-phosphate even in wild-type extracts (Fig. 8.17), as in HCT116 extracts (Fig. 8.3). 
Moreover, 53.3 ± 11.2% of 3′-phosphate was removed from the 3′ overhang substrates 
in the HeLa PNKP knockout extracts with complete removal in the WT (Fig. 8.16). Also, 
DNA-PK inhibitor NU7441 blocked the removal of 3′-phosphate in both WT and PNKP 
knockout extracts, for either substrate. 1 μM NU7441 reduced the phosphate removal 
from the overhang substrate by 49% in WT and 56% PNKP-/- extracts from the overhang 
substrate (Fig. 8.16 lane 3 and 6),  while 10 μM reduced 68% in WT and 57.1% in PNKP-
/- extracts (Fig. 8.16 lane 4 and 7). 
                   On the other hand, 1 μM NU7441 reduced the phosphate removal by 48.6 ± 
2.4% in WT and 35 ± 0.8%  in PNKP -/- (Fig. 8.17 lane 4 and 8), and 10 μM reduced it by 
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68 ± 1.71% in WT and 38.4 ± 0.44%  in PNKP-/-,  from the recessed substrate (Fig. 8.17 
lane 5 and 9).Total Inhibition in the HeLa WT extracts was lower than HCT116 extracts 
due to the increased activity of PNKP owing to the presence of more amount of PNKP in 
the extracts as detected in the Western blot analysis of 50 μg of WT extracts. 
             In addition, when assesed for  DNA 5′-kinase activity in HeLa PNKP knockout 
extracts, 9.6 ± 1.91%  (Fig. 8.18 lane 5) of the 5′ phosphate ends were formed compared 
to 44.5 ± 1.1% (lane 4) in the wild-type extracts after 4 hr incubation. DNA 3′-phosphatase 
activity was found in the nuclear fraction of both the WT and knockout extracts with the 
total removal and digestion of the substrate in WT extract and retention of 78 ± 0.34% 
(Fig. 8.19 lane 7) of the 3′-phosphate in the knockout extracts with little obvious digestion 
of the substrate. 
                 Since the above results of phosphatase assay (Fig. 8.16 and 8.17) and of 
kinase assay (Fig. 8.18) have shown processing very similar to that of processing 
occuring in HCT116 PNKP knockout extracts, it is likely though not certain that 3′-
phosphatase and  5′-kinase activities in the HCT116 PNKP knockout extracts is also due 
to alternative 3′-phosphatases and 5′-kinases, rather than to the minute amount of the 
truncated PNKP detected in that extract by Western blot. DNA-PK inhibition (Fig. 8.16 
and 8.17 B,D), suggest the phosphatase activity found in the knockouts to be a part of 
NHEJ similar to HCT116 knockout extracts (Fig. 8.8). However, there is a wide disparity 
detected in the  3′-phosphatase activity between HCT116 and HeLa nuclear extracts. 
While 80 ± 0.12% (Fig. 8.10) 3′-phosphate ends were processed in HCT116 extracts, only 
22 ± 0.34% (Fig. 8.19) 3′-phosphate ends were processed in HeLa. On the whole, these 
observations suggest the presence of alternatives to the enzyme PNKP. 
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 Fig. 8.16: Effect of PNKP knockout on processing the 3′-phosphate ends of 
overhangs at the DSB’s and susceptibility to DNA-PKcs inhibition: A. Internally 
radio-labeled 3′-phosphate ended overhang substrate was incubated in HeLa WT, and 
PNKP-/-/- extracts for different times as indicated, was proteolyzed and cut with BstXI and 
AvaI and run on a gel. B and C. Percentage of phosphate removal as a function of time 
was measured and plotted for both the extracts. For samples with DNA-PKcs inhibitor 
NU7441 (lane 3,4,6 and 7), the extracts were incubated with NU7441 for 10 min before 
the addition of substrate, then incubated for additional 4 hours. Released bands are one 
base longer than those for TaqαI cut DNA. There was a reduction in total processing in 
the knockouts (lane 17) compared to WT (lane 16). Presence of NU7441 inhibited the 3′-
PNKP- Mouse Monoclonal Antibody  - 379-411 aa 
B.  
C.  
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phosphatase activity, including in the knockouts (lane 3,4,6 and 7) (C = No DMSO/Drug, 
D = DMSO control) (B. n = 3, C. n = 1) 
 
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8.17: Effect of PNKP knockout on processing the 3′-phosphate ends of 
recessed end at the DSB’s and susceptibility to DNA-PKcs inhibition: A) Internally 
radio-labeled 3′ strand with a 3′-phosphate at the recessed end was incubated in HeLa 
WT and PNKP-/-/- extracts for different times as indicated, then were processed similar 
to overhang substrates and run on a gel. B. Percentage of phosphate removal as a 
function of time was measured and plotted for both the extracts. C. For samples with 
DNA-PKcs inhibitor (NU7441), the extracts were incubated with NU7441 (lane 4,5,8 and 
9) for 10 min before the addition of substrate, which were then incubated for 4 hours and 
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the observations were plotted (D). 3′-phosphate processing was incomplete in knockout 
extracts (A. lane 9) compared to the wild-type extracts (A. lane 8).  NU7441 inhibited 
the3′-phosphatase activity in both the extracts (B. lane 4,5,8 and 9).  (C = No DMSO/Drug, 
D = DMSO control) (n = 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8.18: Effect of PNKP knockout on the kinase activity on 5′-hydroxyl substrates: 
Substrates with 5′-hydroxyl substrates labeled on the 5′-strand, were incubated with the 
pure PNKP (lane 2) and T4PNK (lane 3) for 1hr , HeLa WT (lane 4) and PNKP-/-  (lane 
5) extracts for 4 hr, proteolyzed, cut with SmaI and run on a gel. A. Gel picture of the 
migrating 5′-OH (above) and 5′-PO4 (below) at all treatments. B. The formation of  5′-
phosphate was measured as a percentage and plotted for the extracts (lane 4 and 5).  
(** - p < 0.005; Student t test ) (n = 3)  
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Fig. 8.19: 3′-phosphatase activity in HeLa Nuclear extracts: 3′-phosphate overhang 
substrate was incubated in the WT (lane 2,3 and 4) and PNKP knockout  (lane 5,6 and 
7) nuclear extracts made by nuclear/cytoplasmic fractionation, for the indicated times, 
proteolyzed, cut with AvaI and was run on a 20% gel (A). Observed phosphate removal 
was plotted as a percentage for both WT and PNKP knockout extracts. Reduction of the 
removal of 3′-phosphate from the knockout extracts can be clearly depicted from the gel 
(lane 7) compared to WT (lane 4) and from the plot (B). 
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8.15 Pharmacological inhibition of DNA 3′-phosphatase activity: 
              To test whether the 3′-phosphatase activity was attributable to the suspected    
residual PNKP protein detected by western blot in PNKP knockout extracts, PNKP 
inhibitor, ST042146, was used to pharmacologically inhibit the phosphatase activity of the 
PNKP, and thereby reveal the activity of any other DNA 3′-phosphatase acting in the 
context of NHEJ.  
      To evaluate the PNKP inhibition, 100 ng of recombinant PNKP was preincubated for 
10 min with different concentrations ST042164 dissolved in DMSO, before adding the 3′-
phosphate overhang substrate. As seen from Fig. 8.20, after 1 hr of incubation DMSO 
appears to significantly inhibit the phosphatase activity (lane 3), increasing the fraction of 
3′-phosphate remaining from essentially zero to 33% . However, ST042164 was seen to 
increasingly inhibit the activity of the enzyme with increasing concentrations (lane 4-6). 
50 μM concentration of the drug was shown to inhibit most (3.9%, lane 6) of the 3′-
phosphatase activity.    
                  Since we observed no inhibition on DNA 3′-phosphatase in the whole cell 
extracts even at higher concentrations (200 μM) of ST042164, we tried to simulate the 
conditions in which the drug was shown to be effective during its characterization. The 
extracts were diluted (1:125) in a storage buffer similar to the one in which PNKP was 
stored and the phosphatase buffer was used in the reaction (as described in Methods 
7.10), to assess inhibition of 3′-phosphatase activity in the extracts. After 10 min of 
preincubation in the extracts, the 3′-phosphate overhang substrate was added to the 
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diluted extracts. At concentrations of 20μM and 50μM of ST042164, there was a 48 ± 
1.1% and 56 ± 0.72% of reduction in the DNA 3′-phosphatase activity in the diluted 
HCT116 WT extracts after 1 hr incubation (Fig. 8.21 lane 4 and 5), but only about 12.5 ± 
2.3% reduction of the activity in the diluted HCT116 PNKP knockout extracts at both 
concentrations of the drug even after 3 hr incubation (Fig. 8.21 lane 8 and 9). The inability 
of the drug to curb the phosphatase activity in the PNKP knockout extracts propones the 
activity of another factor with a similar function to PNKP, at least the 3′ phosphatase. Also, 
the presence of the drug inhibited the digestion of the substrate in both extracts, 
suggesting a lower conversion to 3′-hydroxyl ends, which are better substrates for the 
exonucleases. Experiments repeated with diluted HeLa extracts gave similar results with 
the drug highly inhibiting the phosphatase activity in WT extracts but not in the PNKP 
knockout extracts.  
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Fig. 8.20: ST042164-mediated inhibition of DNA 3′-phosphatase activity of 
recombinant PNKP: A. Recombinant PNKP (100 ng) was pretreated in the reactions 
with either DMSO (lane 3) or different concentrations of the inhibitor ST042164 (lanes 4-
6), before adding the 3′-phosphate overhang substrate to the reactions. After adding the 
substrate, these reactions were further incubated for 1 hr. The reactions were 
deproteinized, then DNA was cut with AvaI and the products were run on a gel. B. 
Percentage of phosphate removal by PNKP was plotted for different reactions. As seen 
from the gel and the plot there was nearly complete inhibition of phosphate removal from 
the 3′-phosphate ends by ST042164. (C = No drug/DMSO control, D = DMSO control) (n 
= 1) 
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Fig. 8.21: ST042164-mediated inhibition of DNA 3′ phosphatase activity: A. Diluted 
HCT116 WT and PNKP knockout extracts were incubated with the defined concentrations 
of the heated drug for 10 min before addition of a 3′-phosphate overhang substrate. After 
proteolysis and AvaI treatments, products released were run on the gel. B. Image of the 
plot displays the percentage of phosphate removal in both the extracts in the absence 
and presence of ST042164 at the indicated concentrations. Reduction in phosphate 
removal was seen at both the concentrations of the drug (A. lane 4,5,8 and 9) for both 
the extracts with a much smaller inhibition in PNKP knockout extracts (A. lane 8 and 9) 
(C = No DMSO/Drug, D = DMSO control) (n = 2). 
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                                                              IX Discussion 
 
   
                    DNA is one of the four major biomolecules in a cell, encoding genetic 
information which is faithfully carried across generations. Though initially thought to be a 
stable molecule by the discoverers, Watson and Crick, many have since shown that DNA 
is readily susceptible to chemical modifications by external and internal stress factors. 
These alterations if not repaired efficiently can result in numerous unwanted 
consequences such as aging (Hoeijmakers, 2009), cancer (Loeb & Harris, 2008) (Paz-
Elizur et al., 2008) and neurological development disorders (McKinnon, 2009).  A battery 
of robust DNA repair pathways have evolved to counter cytotoxic and mutational damage 
in a cell, functioning in a lesion-specific manner to ensure genomic stability. 
                 Many studies have shown that defects in the DNA damage response and 
repair pathways are a double-edged sword, either leading to the development of tumors 
or rendering them resistant to cancer chemotherapy and radiotherapy whose primary goal 
is to kill cancer cells mostly by inducing DNA damage (Hosoya & Miyagawa, 2014).  Thus, 
DNA response/repair factors have become potential therapeutic targets in the the recent 
years (Hosoya & Miyagawa, 2014) (Zhu, Hu, Hu, & Liu, 2009) (Bhattacharjee & Nandi, 
2017). In every repair pathway, there are a plethora of enzymatic activities such as 
nucleases, helicases, polymerases, topoisomerases, recombinases, ligases, 
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glycosylases, demethylases, kinases, and phosphatases modifying the damaged DNA in 
a regulated fashion (Ciccia & Elledge, 2010a).  
        One such enzyme, Polynucleotide kinase phosphatase (PNKP), a bifunctional 
enzyme with DNA 5′-kinase and 3′-phosphatase activities, is required to modify ends of a 
DNA break before ligation. Occurrence of 3′- phosphate termini at the DNA breaks is 
common and can  arise from a number of sources including reactive oxygen species,  
Tdp1 processing of stalled topoisomerase I complexes generated by the drug 
camptothecin  (Yang et al., 1996) and as intermediates in  a sub-pathway of base excision 
repair of oxidative base damage (Wiederhold et al., 2004).  Nonetheless, occurrence of 
the 5′-hydroxyl termini is rare, being produced due to strand scission, e.g. ionising 
radiation (Coquerelle, Bopp, Kessler, & Hagen, 1973) camptothecin treatment,  (Hsiang, 
Hertzberg, Hecht, & Liu, 1985) or by DNase II action. PNKP plays a crucial role in the 
repair of the complex double strand and single strand breaks induced by oxidative factors 
or repair-intermediates produced during their resolution.  Like any other DNA repair factor, 
PNKP mutations have been identified as an etiology for neurological disorders 
(Dumitrache & McKinnon, 2017). Moreover, its involvement in various repair pathways 
made it an attractive target for chemotherapy of cancer (Allinson, 2010).  
     There is a considerable evidence regarding the participation of PNKP enzyme in 
NHEJ, one of the two major DSBR pathways (Chappell, Hanakahi, Karimi-Busheri, 
Weinfeld, & West, 2002b) (Chappell et al., 2002b), with   accumulation of double-strand 
breaks in mouse models of PNKP deficiency (Shimada, Dumitrache, Russell, & 
McKinnon, 2015). However, no other factor has yet been identified to take over the role 
of PNKP in the repair of the 3′-phosphate and 5′-hydroxyl lesions at DSBs. An attempt 
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was made in our lab to screen for any such factor either by knocking down PNKP in 
HCT116 or treatment with a PNKP inhibitor, A12B4C3. None of these approaches were 
able to produce a distinction in the repair of 3′-phosphates DNA ends resulting from NCS 
treatment, as evidenced by screening the formation of 3′-hydroxyl ends by Ligation-
mediated PCR (LMPCR). Therefore, for our current study, we employed CRISPR 
mediated PNKP knockout cells to ensure a complete loss of PNKP activity. Initially, 
HCT116 cells with PNKP knockout were acquired from Dr. Weinfeld’s lab, and the 
knockout status was verified with the in-house mouse anti-PNKP monoclonal antibody 
raised against the N-terminal aa 1-140 peptide of the human PNKP enzyme. Survival and 
53-bp1 repair foci (marker for NHEJ) assays done after NCS treatment of wild-type and 
PNKP knockout cells.  There was a reduced survival and persistence of the repair foci in 
knockout cells. 
        Further, we proceeded to evaluate the specific enzymatic activities of PNKP, i.e., 
DNA 3′-phosphatase and 5′-kinase functions, in the absence of PNKP. To determine the 
same, specific radiolabeled DSB substrates were constructed with either a 3′-phosphate, 
3′-phosphotyrosine or 5′-hydroxyl ends and cell-free whole cell extracts of HCT116 WT 
and PNKP knockout cells to process these substrates. Substrates with a 3′-phosphate 
end have either a partial complementary overhang or a complementary recessed end. 
Even in the absence of PNKP, removal of ~80% of the 3′-phosphate was seen for the 
overhang substrates. However, there was a severe limitation (~24%) in the processing of 
the recessed ends.  Electrophoretic mobility shift assays done to characterize the DNA 
substrates have shown recessed end substrate to be a better binder than the overhangs 
(Havali-Shahriari, Weinfeld, & Glover, 2017). Surprisingly our experiments have shown 
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incomplete removal of 3′-phosphate from the recessed ends (Fig. 8.3). Structural studies 
of PNKP have demonstrated a narrow and deep active site cleft which could 
accommodate single but not double-stranded substrates (Coquelle, Havali-Shahriari, 
Bernstein, Green, & Glover, 2011b). The minimal substrate required for the catalysis in 
the phosphatase domain is a single-stranded three-nucleotide 3′-phosphorylated DNA 
(Bernstein et al., 2005). Destabilization of the double strand must occur to place the 3′-
phosphate end of one strand in the narrow 3′-phosphatase cleft. Therefore, it can be 
hypothesized that the 3′-phosphate from the 3′-end with a 3 base overhang was easily 
accessible and hence the removal was rapid and complete, while the destabilization 
energy spent in accessing the 3′-phosphate at the recessed end, likely limited the catalytic 
activity on the substrate. Further, evaluation of processing of 3′-phosphotyrosyl 
substrates in the extracts revealed an accumulation of 3′-phosphates in the knockout 
extracts but not in the WT extracts, suggesting a deficiency of PNKP in the extracts.  
       APE1, an important constituent enzyme of BER is known to resolve various 3′ end 
blocks at SSB’s, including 3′–phosphatases (M. Li, Wilson, & III, 2014).   However, the 3′-
PG and 3′-phosphate removal activities of APE1 are ∼70-fold lower than the 
endonuclease activity and it acts efficiently only at the recessed end of a double-strand 
break, at least for 3′-phosphoglycolates. It can be hypothesized that in the absence of 
PNKP, APE1 can take over the 3′-phosphatase function. Another enzyme Aprataxin is 
shown to repair DNA single-strand breaks with damaged 3′-phosphate and 3′-
phosphoglycolate ends (Takahashi et al., 2007). On the other hand, Aprataxin also has 
an FHA domain similar to PNKP and interacts with CK2- phosphorylated XRRC4 similarly 
to PNKP, in a mutually exclusive manner (Ahel et al., 2006b). Hence, there can be a 
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competition between the two proteins in binding to XRCC4. One possible deciding factor 
for the interaction is the DNA substrate specificity. However, the primary function of 
Aprataxin is to resolve the adenylated 5ʹ- ends of the DNA due to abortive ligation 
mediated by Ligase IV.  In wild-type extracts, spontaneous activity of PNKP renders the 
ends ligatable almost immediately. Nonetheless, lack of PNKP in the knockout extracts 
results in the persistence of the 3′-phosphate at breaks, and if accompanied by 5ʹ-
phosphate at the other end, there will be accumulation of 5ʹ-AMP (adenyl) ends due to 
abortive ligation. This accumulation along with the lack of the competitive PNKP might 
enhance the amount of Aprataxin binding with pXRCC4 at the non-ligated break. This 
increased presence of Aprataxin at the break might result in the dephosphorylation of the 
3′-ends.  However, APE1 and Aprataxin were shown to possess 3′-phosphatase activity 
at the SSB’s. Experiments done to block the ligation of the opposite strand which can 
create a suitable substrate for APE1 and Aprataxin did not inhibit the repair of the 
damaged strands, limiting the evidence of their involvement in the repair of DSBs in PNKP 
knockout extracts. Recombinant protein assays with APE1 and Aprataxin, with and 
without core NHEJ recombinant proteins, using DSB substrates might reveal the function 
of these proteins.  
                       All the above 3′-phosphate substrates had a 5′-phosphate end enabling the 
end joining at the 3′-hydroxyl ends. Though the presence of a 5′-hydroxyl end is not 
necessary for the extension of the DNA strand at 3′ end, ligation of the stand does. Any 
block at the 5′ end can be successfully overcome by strand displacement. Our substrates 
possessing 5′-OH ends, labeled on the 3′-end displayed end joining in the PNKP knockout 
extracts without any evidence of strand displacement (Fig. 8.6 B). This finding was an 
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indirect measure of the kinase function in the PNKP knockout extracts. Direct evidence 
of the kinase activity in the knockout extracts was obtained by incubating 5′-OH substrates 
labeled on the same strand. The observed total kinase activity in the extracts was less 
than the phosphatase activity (Fig. 8.6).  
              Before deducing the presence of other repair factors that might function similarly 
to PNKP, western blot experiments with antibodies that recognize different epitopes on 
the PNKP, were done to assess the possibility of the presence of residual PNKP or any 
other isoforms of PNKP. Unfortunately, these blots have disclosed a band running close 
to PNKP. The intensity of this band was almost 1/13th of of the band intensity at the same 
concentration of the protein in WT (Fig. 8.12). Meanwhile, HeLa PNKP knockout cells 
were obtained, and after confirming a clean knockout, DNA 3′ phosphatase and direct 5′-
kinase assays were repeated, reproducing very similar results as in HCT116 PNKP 
knockout extracts. Although, ST042164, PNKP inhibitor obtained from Dr. Weinfeld’s 
laboratory, inhibited the 100 ng pure PNKP’s 3′-phosphatase activity at 10 μM 
concentration (Fig. 8.20), there was no effect was seen in the extracts even at 200 μM 
concentration. However, when used in 1: 125 diluted extracts, marked inhibition was 
visible in WT extracts but not in PNKP knockout extracts (Fig. 8.21). These findings gave 
a positive indication of the presence and activity of other DNA 3′-phosphatases in the cell.  
                   Since the 3′-phosphatase activity was observed at the DSB’s, we wanted to 
evaluate if this function is a part of NHEJ. During NHEJ, autophosphorylation of the DNA 
DSB bound DNA-PK complex is required for the accessibility of the ends to the end 
processing proteins which take part in NHEJ. By blocking the autophosphorylation of 
DNA-PK by the inhibitor, NU7441, this access can be limited. In both the extracts, the 
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phosphatase activity observed appeared to be a function of NHEJ as revealed by the 
DNA-PK inhibitor NU7441 treatment (Fig. 8.8). Moreover, availability of the DNA 
substrate ends for 3′-phosphate end processing to a non-specific phosphatase (CIP) even 
in the presence of NU7441 validates the above statement (Fig. 8.9).  A cytoplasmic 
protein phosphatase enzyme, DUSP 27, (Friedberg et al., 2007) was believed to 
dephosphorylate DNA 3′ ends as it was identified to have a synthetic lethality with PNKP 
loss. Also, Alkaline phosphatase is a membrane-bound and cytoplasmic enzyme that can 
non-specifically dephosphorylate either 3′ or 5′ ends. However, the nuclear extracts 
retained the 3′ phosphatase activity even in PNKP knockout extracts, suggesting a 
nuclear presence of the unknown enzyme (Fig. 8.10 and 8.19).  
 
 
 
 
 
 
 
 
 
 
136 
 
 
                          
 
 
 
 
 
 
 
 
 
 
 
Fig. 9.1: Role of DNA-PK in NHEJ and DNA DSB processing: Formation of DNA-PK 
complex (Ku + DNA-PKcs) at the DSBs activates the kinase function on DNA-PKcs 
resulting in a series of phosphorylation events which moves the complex away from the 
ends and allowing for the accumulation of XLF-XRCC4-Ligase IV (ligation complex), at 
the DSBs. Accessory repair factors accumulate on the scaffold of this ligation complex to 
process the damaged ends and render them ligatable. By using a DNA-PK inhibitor, 
NU7441, which blocks the kinase active site, all the phosphorylation events are blocked 
thereby inhibiting the accumulation of either ligase complex or accessory factors. Thus, 
PNKP or its alternative DNA 3′-phosphatase and 5′-kinase enzyme(s) (if it is a part of 
NHEJ process), cannot function efficiently in the presence of NU7441. In our experiment 
the DNA 3′-phosphatase and 5′-kinase enzyme(s) appeared to be a part of NHEJ as the 
function was blocked in the presence of NU7441 (Fig. 8.10 and 8.19). 
NU7441 
137 
 
  
               The NHEJ mediated repair of the double strand break requires more than 15 
factors including the core and accessory factors to form complexes and resolve the 
complex strand breaks. Among the core proteins, XRCC4 is thought to be a central 
scaffold that coordinates handoff of DNA repair intermediates between various DNA 
repair enzymes (Aceytuno et al., 2017a). PNKP is shown to interact with both non-
phosphorylated (XRCC4) and phosphorylated XRCC4 (pXRCC4), the latter being strong. 
However, this interaction with pXRCC4 reduces the PNKP activity requiring DNA Ligase 
IV in reversing the inhibitory effect of pXRCC4 on the turnover of the PNKP at the 5′-
phosphate ends. Structural studies have shown that XRCC4 forms a 1:2:1 PNKP: 
pXRCC4: Ligase IV complex.  XRCC4 and XLF homodimer proteins interact head to head 
forming long helical protein filaments to facilitate DNA double-strand break repair. 
(Mahaney, Hammel, Meek, Tainer, & Lees-Miller, 2013).  
         Further, the weak interaction between the PNKP catalytic domain and XRCC4–
Ligase IV, seem suitable to position PNKP to gain access to DNA within the XRCC4-XLF 
filament (Aceytuno et al., 2017a). Based on these interacting studies, we wanted to 
explore the role of XRCC4 and XLF in the activity of PNKP in XRCC4 knockout HCT116 
and Bus cell (deficient in XLF) extracts, respectively. Many studies reported the influence 
of XRCC4 on the kinase activity of the PNKP, with limited data on the phosphatase 
function. When both the activities were assayed, as expected, there was reduction 
observed for both the activities of PNKP in XRCC4 knockout extracts, only to be increased 
after complementation of the protein with an exuberant end joining of both the substrates 
(Fig. 8.11). Even though an increase, in the end joining of the partially complementary 3′-
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phosphate substrates is conceivable, there was end joining of 5′-hydroxyl substrates with 
no complementarity in the overhang.  This end joining appeared as a diffuse band, 
proposing a small resection at these ends (Fig. 8.11). This observation once again 
illustrates the ability of XRCC4 to promote ligation at the incompatible ends (Pannunzio, 
Watanabe, & Lieber, 2017). The inability of the added pure protein PNKP to restore the 
kinase activity in the absence of XRCC4 might be due to the reduced turnover of the 
PNKP after DNA 5′ phosphorylation (Mani et al., 2010b).This increased affinity of any 
protein to its processed substrate is to protect the DNA ends until passed on to next 
enzyme in the repair pathway (Hsiang et al., 1985). Further, there was no effect of XLF 
deficiency on the phosphatase activity in the Bus cell extracts, but the kinase activity was 
almost reduced to half, suggesting a role for XLF in influencing the processing of the 5′-
hydroxyl ends. As expected, presence end joining was evident only in the presence of 
XLF, for the 3′-phosphate substrates which have a complementarity in the overhangs. 
However, XLF was not able to join the non-complementary ends of the 5′-hydroxyl 
substrates. 
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Fig. 9.2: Role of XLF-XRCC4-Ligase IV complex in influencing PNKP activity: 1. 
XLF-XRCC4-Ligase IV complex forms heterofilaments at the DSBs (for convenience 
single complex is depicted). PNKP accumulates on the scaffold of XLF-XRCC4-Ligase IV 
complex at the DSB for processing the DNA 5′-hydroxyl ends (also 3′-phosphate ends) 
and phosphorylates 5′-OH ends. 2. XRCC4-Ligase IV complex is required for the turnover 
of PNKP at the 5′-phosphorylated ends for reducing the affinity of PNKP to these 
processed ends, so that it can act on other 5′-OH ends. Hence, an increase in kinase 
activity (and phosphatase activity) was detected on adding back XRRC4/Ligase IV 
complex to XRCC4 knockout extracts (Fig. 8.11). However, in our experiments XLF has 
also enhanced the kinase activity (Fig 8.12), thus it is hypothesized that the XLF-XRCC4-
Ligase IV complex increases the turnover of PNKP and in the absence of this complex, 
though PNKP can process the 5′-OH ends, remains bound to its substrates thereby 
limiting its activity on other substrates. XLF-XRCC4-Ligase IV complex is depicted in the 
box below. 
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          Ligation-mediated PCR experiments (LMPCR) done in the lab to visualize the 
processing of DNA 3′-phosphate ends created by treatment of cells with the non-protein 
chromophore of Neocarzinostatin (NCS-C),  have shown very rapid and similar 3′-
dephosphorylation in both wild-type and PNKP knockout HCT116 cells at 37 °C. 
However, at 22 °C, there was a distinct delay in 3′-dephosphorylation of DSBs in PNKP 
knockout cells, with 8-fold fewer 3′-hydroxyl DSB termini than in wild-type cells 5 min after 
NCS-C addition and a 2 fold fewer at the 40 min time point at 22 °C. HeLa cells on the 
other hand showed a reduction of processing of 3′-phosphate with 3-fold fewer 3′-hydroxyl 
DSB termini at 5 and 15 min after treatment in PNKP knockout cells at 37 °C, although 
by 40 min, processing was similar to wild-type. At 22 °C there were fewer 3′-hydroxyl 
termini at least by 2-fold at all times with a 4-fold reduction at 40 min. These in-vivo 3′-
phosphatase assays, while they confirm a partial deficiency in 3′-dephosphorylation in 
PNKP knockout cells, also suggest the presence of an alternative DNA 3′ phosphatase 
enzyme(s) which can process the 3′-phosphate ends in the absence of PNKP, and show 
that it is active in cells and not only extracts. 
                      The disparity found in the DNA 3′-phosphatase activity detected in the 
extracts and cells from the survival assays (decreased survival of the knockout cells 
despite the repair seen in our 3′-phosphatase assays), can be explained by the creation 
of other lesions such as SSB’s and 3′ phosphoglycolates by NCS, which in most cases 
require PNKP, delaying or interfering with the complete DNA repair, surmounting to cell 
death. Presence of the 53BP1 foci even after a long time suggests unrepaired DSB’s, 
with some of the DSB’s going into a delayed repair in G1, (resection dependent NHEJ or 
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Alt-NHEJ) which can lead to chromosomal translocations (Jeggo & Löbrich, 2017), or 
repaired by HR in G2 (as the cells are non-synchronized). 
                     Resistence to chemotherapy is seen as major problem in developing new 
tartgets, especially the cell DNA damage  response and repair factors. An enormous 
amount of redundancy in these factors and the ability of the cancer cells to hijack various 
pathways for the survival, poses a problem for a generalized targetting of the cancers. 
Hence, before considering a factor as a desired target, it is imperative to rule out 
redundancy. In the current scenario, PNKP appears to be a lucrative target due its crucial 
role in various repair pathways. However, as with any other factor, PNKP function might 
be duplicated by a redundant factor, whose function might not have been overtly obvious 
in PNKP’s presence. Though lack of PNKP resulted in increased damage to cells, cancer 
cells could utilise PNKP’s alternative for the survival. Hence, it would be wise to identify 
these alternative 3′-phosphatase factors and develop pharmacogial agents to block their 
activity in order to tackle future cancer therapy resistance. 
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                                                                          X Conclusion 
 
Repair of complex lesions at the double strand breaks requires processing of the ends by 
accessory factors. The nature of these lesions can be a deciding factor for the choice of 
repair pathway/repair factor that will act upon these lesions. From the Thymine glycol (Tg) 
study, we found that the Tg positioned at the fifth position is a better substrate than Tg at 
third position for the BER repair protein, hNTH1, precluding the availability of these ends 
for Non-homologous end joining. Similarly, from the PNKP experiment, we found that the 
3′-phosphate at an overhang is better removed by the enzyme PNKP, than the one at the 
recessed end. However, PNKP seemed to be the pivotal enzyme processing the 
recessed 3′ ends.  
   Observations made in HCT116 and HeLa PNKP knockout extracts and cells suggest 
the presence of an alternative enzyme(s) to PNKP, although, these enzymes play a 
limited role in the absence of PNKP as seen by the survival assays.  However, the 
presence of minute amounts of PNKP must be ruled out by trying to immuno-deplete the 
residual PNKP in the knockout extracts. Also, a recombinant ApeI which has a weak 3′ 
phosphatase activity, or Aprataxin can be tested either alone or in combination with other 
NHEJ proteins such as XRCC4-Ligase IV to disclose their activity in the context of NHEJ, 
in the absence of PNKP. Further, possibility that the increase lethality of the PNKP 
knockout cells following treatment with NCS is due to increased DSB mis-joining resulting 
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in lethal chromosome aberrations, can be investigated by FISH experiments to detect 
chromosomal translocations. Also, by column separation of proteins in the PNKP 
knockout extracts, different fractions can be tested for the presence of the DNA 3′-
phosphatase and 5′-kinase functions. After multiple column preparations (e.g. size-
exclusion, ion-exchange, and DNA affinity), the alternative DNA 3′-phosphatase(s) and 
5′-kinase(s) might be isolated and identified by mass spectrometry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
144 
 
 
 
                                                                       
 
                                                                           
                                                                  Appendix I 
                                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Restoration of DNA 3′-phosphatase activity by recombinant PNKP: To 
determine the loss of 3′-phosphatase activity in knockout extracts is due to lack of PNKP, 
recombinant protein (100 ng) was added to the Hct116 and HeLa PNKP knockout extracts 
and incubated for different times. A) Plot derived from the observed percentage of 
restoration of 3′-phosphatase activity on one base 3′-over hang substrate with time, in 
HCT116 extracts. B) Gel image allowing the restoration of 3′-phosphatase activity by 
PNKP addition on 3-base 3′-phosphate overhang substrate in HeLa knockout extracts. 
The incubation time for all the reactions was 90 sec. As seen from the plot and gel, there 
was restoration of the activity similar to activity seen in wild-type extracts.  
A. 
B. 
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Human HCT116 PNK gene knock out Confirmation by DNA sequencing 
Alignment of CRISPR clone 3-14 with PNK Exon 3 sequences (WT) 
65 nucleotide were deleted and 10 nucleotide were rearranged in Allele 1; 78 nucleotide 
were inserted and 2 separate nucleotides were mutated in Allele 2 
 
E3-14-1         CTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCT 
E3-14-2         CTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCT 
PNK-Exon3       CTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCT 
                ************************************************************ 
 
E3-14-1         CTGGGGGTGGGGGACACACTGTATTTGGTCAATGG------------------------T 
E3-14-2         CTGGGGGTGGGGGACACACTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGG 
PNK-Exon3       CTGGGGGTGGGGGACACACTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGG 
                ************************************************************ 
 
E3-14-1         GAAGATGCC--------------------------------------------------- 
E3-14-2         GAAGAGACCCGCACACCAGAATCCCAGCCAGATACTCCCGCACACCAGAATCCCAGAAGA 
PNK-Exon3       GAAGAGACCCGCACACCAGAATCCCAGCCAGATACTCC---------------------- 
                **************************************                       
 
E3-14-1         ------------------------------------------------------------ 
E3-14-2         GACCCGCACACCAGAATCCCAGCCAGATACTCCCGCACACCAGAATCCCAGAAGAGACCT 
PNK-Exon3       --------------------------------------------------------GCCT 
                                                                         *** 
 
146 
 
E3-14-1         --------TCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAGAAGCATATG 
E3-14-2         GGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAGAAGCATATG 
PNK-Exon3       GGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAGAAGCATATG 
                ************************************************************ 
E3-14-1         CGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTGTTCACCGCAGCTGGG 
E3-14-2         CGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTGTCCACCGCAGCTGGG 
PNK-Exon3       CGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTGTTCACCGCAGCTGGG 
                ********************************************** ************* 
 
E3-14-1         GTGAAACCCCAGGGCAAG 
E3-14-2         GTGAAACCCCAGGGCAAG 
PNK-Exon3       GTGAAACCCCAGGGCAAG 
                ******************   
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Human HeLa PNK gene knock out Confirmation by DNA sequencing 
There are three copies of PNK in HeLa cells. Genomic DNA sequences around short 
guide RNA site of exon3 in clone 3-1-1 were sequenced. 
DNA sequencing result showed that all three copies of PNK were modified. 
 
Copy one 
PNK3            CACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACAC  
PNK3-1-1c       CACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACAC  
                ************************************************************  
 
PNK3            ACTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGGGAAGAGACCCGCACACC  
PNK3-1-1c       ACTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGGGAAGAGACCCGCACACC  
                ************************************************************  
 
PNK3            AGAATCCCAGCCAGATACTCCGCCTGGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGA  
PNK3-1-1c       AGAATCCCAGCCAGATACTCCGCCTGGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGA  
                ************************************************************  
 
PNK3            TGCTGAGCTGCCGAAG-AAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGA  
PNK3-1-1c       TGCTGAGCTGCCGAAGTAAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGA  
                **************** *******************************************  
 
PNK3            AGTTGCTAGTGTTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGA  
PNK3-1-1c       AGTTGCTAGTGTTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGA  
                ************************************************************  
 
PNK3            GGGCTGAGGGAGCCGCCACAGACTGGGACCCAATCCCACGTTTGTTGCGTGCTCTCA  
PNK3-1-1c       GGGCTGAGGGAGCCGCCACAGACTGGGACCCAATCCCACGTTTGTTGCGTGCTCTCA  
                ********************************************************* 
1 nucleotides were inserted into clone 3-1-1. 
 
Copy two 
PNK3            ACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACACA 
PNK3-1-1a       ACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACACA                               
                ************************************************************  
 
PNK3            CTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGGGAAGAGACCCGCACACCA 
PNK3-1-1a       CTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGGGAAGAGACCCGCACACCA                     
                ************************************************************  
 
PNK3            GAATCCCAGCCAGATACTCCGCCTGGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGAT 
PNK3-1-1a       GAATCCCAGCCAGATACTCCGCCTGGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGAT  
                ************************************************************  
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PNK3            GCTGAGCTGCCGAAGA-------------------------------------------- 
PNK3-1-1a       GCTGAGCTGCCGAAGACCTACAACCAGCTGTTCGAGGAAAACCCCATCAACGCCAGCGGC  
                ****************                                              
 
PNK3            ------------------------------------------------------------ 
PNK3-1-1a       GTGGACGCCAAGGCCATCCTGTCTGCCAGACTGAGCAAGAGCAGACGGCTGGAAAATCTG                                                                               
 
PNK3            ------------------------------------------------------------ 
PNK3-1-1a       ATCGCCCAGCTGCCCGGCGAGAAGAAGAATGGCCTGTTCGGAAACCTGATTGCCCTGAGC                                                                              
 
PNK3            -------AGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTG 
PNK3-1-1a       CTGGGCAAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTG          
                       *****************************************************  
 
PNK3            TTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGAGGGCTGAGGGA 
PNK3-1-1a       TTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGAGGGCTGAGGGA  
                ************************************************************  
 
PNK3            GCCGCCACAGACTGGGACCCAATCCCACGTTTGTTGCGTGCTCTCA            
PNK3-1-1a       GCCGCCACAGACTGGGACCCAATCCCACGTTTGTTGCGTGCTCTCA  
                **********************************************                 
171 nucleotides were inserted into clone 3-1-1. 
 
 
Copy three 
PNK-E3          CTCCCTCTCTTTCTGCAGCTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAG      
PNK3-1-1jR      CTCCCTCTCTTTCTGCAGCTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAG 
                ************************************************************ 
 
PNK-E3          CCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACACACTGTATTTGGTCAATGGCCTCCAC     
PNK3-1-1jR      CCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACACACTGTATTTGGTCAATGGCCTCCAC 
                ************************************************************ 
 
PNK-E3          CCACTGACCCTGCGCTGGGAAGAGACCCGCACACCAGAATCCCAGCCAGATACTCCGCCT 
PNK3-1-1jR      CCACTGACCCTGCGCTGGGAAGAGACCCGCACACCAGAATCCCAGCCAGATACTCCGCCT 
                ************************************************************ 
 
PNK-E3          GGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAG---------
PNK3-1-1jR      GGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAGTAAGCGCGG 
                ***************************************************    
 
PNK-E3          ------------------------------------------------------------
PNK3-1-1jR      CGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCTTAGCGCCCGCTC 
 
PNK-E3          ------------------------------------------------------------
PNK3-1-1jR      CTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAA 
 
PNK-E3          ------------------------------------------------------------
PNK3-1-1jR      ATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAAC 
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PNK-E3          ----------------AAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAA 
PNK3-1-1jR      TTGATTTGGGCGATGGAAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAA 
                                ******************************************** 
 
PNK-E3          GTTGCTAGTGTTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGAG 
PNK3-1-1jR      GTTGCTAGTGTTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGAG 
                ************************************************************ 
 
PNK-E3          GGCTGAGGGAGCCGCCACAGACTGGGACCCAATCCCACGTTT               
PNK3-1-1jR      GGCTGAGGGAGCCGCCACAGAC-------------------- 
                **********************    
205 nucleotides were inserted into clone 3-1-1.                              
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